



Faculty of Health Sciences 
Department of Clinical Medicine 
 
Chronic Pelvic Pain in women 
Group-based multimodal physical therapy 
 
Ane Sigrid Nygaard 
























Chronic Pelvic Pain in women 














Dissertation from the Arctic University of Norway 
Faculty of Health Sciences 




The Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health (NKIB) 
































































Table of Contents 
Acknowledgements .................................................................................................................... 1	
List of papers .............................................................................................................................. 4	
Abstract ...................................................................................................................................... 5	
1	 Introduction .......................................................................................................................... 7	
2	 Background .......................................................................................................................... 9	
Chronic pelvic pain ...................................................................................................... 9	
Definitions ............................................................................................................... 9	
Underlying causes and pain mechanisms .............................................................. 10	
Classification ......................................................................................................... 14	
Prevalence and characteristics .............................................................................. 17	
The female pelvis – anatomy and functions .............................................................. 19	
Treatment of chronic pelvic pain ............................................................................... 21	
Physical therapy .................................................................................................... 22	
Patient education ................................................................................................... 23	
Psychological treatments ....................................................................................... 23	
Group-based versus individual treatment ............................................................. 24	
Evidence base for multimodal treatment .............................................................. 24	
3	 Aims of the study ............................................................................................................... 29	
4	 Materials and methods ....................................................................................................... 31	
Literature search ........................................................................................................ 31	
Study design ............................................................................................................... 31	
Participants ................................................................................................................ 31	
Study intervention ...................................................................................................... 33	
Movement and body awareness therapy ............................................................... 34	
Patient education ................................................................................................... 35	
Acceptance and Commitment Therapy ................................................................. 35	
 
  
Comparator group ...................................................................................................... 35	
Data collection ........................................................................................................... 36	
Outcome measures ..................................................................................................... 36	
Pelvic pain intensity (Papers I, II and III) ............................................................. 37	
Movement patterns (Paper II) ............................................................................... 37	
Sexual function (Papers I and II) .......................................................................... 37	
Subjective health complaints (Papers I and II) ..................................................... 38	
Symptoms of anxiety and depression (Papers I, II and III) .................................. 38	
Urinary incontinence (Papers I and II) .................................................................. 39	
Anal incontinence (Papers I and II) ...................................................................... 39	
Obstructed defecation ........................................................................................... 39	
Sample size calculation .............................................................................................. 40	
Randomization and blinding ...................................................................................... 40	
Statistical analysis ...................................................................................................... 40	
Ethical considerations, trial registration and funding ................................................ 42	
5	 Results ................................................................................................................................ 43	
Participant flow, dropouts and adherence .................................................................. 43	
Paper I ........................................................................................................................ 46	
Paper II ....................................................................................................................... 46	
Paper III ..................................................................................................................... 47	
6	 Discussion .......................................................................................................................... 49	
Summary of main findings ........................................................................................ 49	
Interpretation of the results ........................................................................................ 49	
Paper I ................................................................................................................... 49	
Paper II .................................................................................................................. 51	
Paper III ................................................................................................................. 53	
Discussion of methodological aspects ....................................................................... 55	
 
  
Study design .......................................................................................................... 55	
Study sample ......................................................................................................... 56	
Blinding ................................................................................................................. 57	
Outcome measures and data collection ................................................................. 58	
Study intervention and comparator group ............................................................. 60	
Statistical considerations ....................................................................................... 61	
7	 Conclusions ........................................................................................................................ 63	
8	 Clinical implications and future research .......................................................................... 65	







List of Tables 
Table 1 Neural pain processes ................................................................................................. 12	
Table 2 The European Association of Urology’s classification of chronic pelvic pain .......... 16	
Table 3 Population based studies on women with chronic pelvic pain ................................... 18	
Table 4 Randomized controlled trials of multimodal interventions including physical therapy 
for women with chronic pelvic pain ........................................................................................ 26	
Table 5 Non-randomized studies of multimodal interventions including physical therapy for 
women with chronic pelvic pain .............................................................................................. 27	
Table 6 The main baseline characteristics of the participants in Papers I, II and III ............... 45	
 
List of Figures 
Figure 1 A bio-psycho-social model of chronic pelvic pain. …………………………..….. 10 
Figure 2 Muscles of the female pelvis. …………………………………………………….. 19 
Figure 3 The female pelvis, sagittal view……………………………………………………20  
Figure 4 Algorithm for eligible participants……..…………………………………………. 32 
Figure 5 Timeline of the multimodal intervention..…………………………………………34 
Figure 6 Participant flow through the study……….…………………………………..…… 44 
Figure 7 Mean pelvic pain intensity at different time points for the two groups…………... 47 
 
List of Appendices 
Appendix 1 Schedule for the study intervention 
Appendix 2 TidiER Checklist 
Appendix 3 Information letter to physical therapists in primary care 
Appendix 4 Interview guide baseline 
Appendix 5 Interview guide posttest 
Appendix 6 Sexual function questionnaire 




Throughout the work with this thesis I have received a great deal of support and assistance. 
The generous contributions from the Norwegian Fund for Post-Graduate Training in Physical 
Therapy and the Northern Norway Regional Health made the conduction of the study 
possible, and the grants are greatly appreciated.  
 
Many individuals have contributed along the way. First of all, I wish to express my deepest 
gratitude to the women that shared their very personal experiences. Your stories gave me new 
and important insights, and without you this study would not have been possible. 
 
To my supervisors: Thank you for following me all the way, despite several delays and 
postponements. 
Professor Pål Øian was my main supervisor from the start and throughout the process. I truly 
appreciate your experienced and wise guidance, precise feedback and encouraging support, 
also when the road got tough.  
My second main supervisor, associated professor Gro Killi Haugstad; your knowledge in the 
field of chronic pelvic pain has been of great value. Thank you for all the encouraging and 
enlightening talks at your office, for sharing your experiences and for your unconditional 
belief in the importance of this project.  
My co-supervisor associated professor Mona Stedenfeldt; without your enthusiasm and 
optimism the project would not have been initiated. Thank you for your clear and innovative 
thoughts, for encouraging and inspiring me, and for helping me change perspective when 
needed. I greatly appreciate the collaboration with you during these years!  
To associate professor Mona Birgitte Rydningen; I truly appreciate your commitment and 
support during these years. Thank you for all the hours spent helping me! Your direct and 
wice input have challenged and encouraged me, and undoubtedly improved the thesis. 
The statisticians Marthe Larsen and professor Tom Wilsgaard deserve a big thank you for the 
informative discussions and advice, which was crucial to complete the thesis. My thanks also 
go to professor Rolv-Ole Lindsetmo for supporting the project from the start and for 
contributing as a co-author. Slawomir Wojniusz, thank you for scoring all the SMT-videos, 
 
2  
which was an essential part of the data-material in the thesis. I also want to thank you for 
scientific discussions along the way and for contributing as a co-author.  
My sincere gratitude goes to Anne Tine Vold, Cathrine Boge-Olsnes and Karsje Westerdijk 
for introducing me to the study intervention, for all the discussions and talks, and for your 
friendship and support throughout the period. I really admire your skills and knowledge!  
Marthe Figenschau Eikedal, thank you for performing the data collection during my two 
maternity leaves. Your work was essential to complete the study! 
To all of you at NKIB; although miles apart you have been my closest and highly valued 
colleagues. Especially, I would like to express my appreciation to Marianne Nicolaisen and 
Lotte Lindstrøm Eliassen for being “solution-oriented” and for always helping me with the 
practical challenges. Torunn Kværnstuen Pedersen – thank you for sharing your great 
knowledge and for all the practical assistance during the planning of the study and recruitment 
of participants. Wenche Marie Andersen, you have been a great successor to Torunn, always 
helpful and trustworthy.  
The study could not have been conducted without the assistance from Inger Sperstad and 
Ingrid Sandstad at the Clinical Research Department at UNN. Thank you! 
Thank you to my former leader, Anne Ringheim for your support throughout the study, and to 
my colleagues at the Department of Physical Therapy at UNN. Although not located in the 
same part of the country during these years I have felt strong affiliation to you – and I still do. 
I also wish to express my gratitude to the Faculty of Physical Therapy at OsloMet for inviting 
me to join the MUSK Health research group and for letting me have an office-place. This has 
given me valuable scientific input, a “place to go to” and not least, valuable acquaintances. 
Especially I want to thank Mette, Kristine and Marthe for the valuable meetings we have had! 
To all my dear friends, near and far: I am so grateful for your friendships, knowing that you 
are there means a lot to me! To my family – thank you for all the practical help and for being 
there during these years. I truly am privileged to have a supporting network like you are! 
To Ingrid and Marte - you have made it impossible to focus on the PhD 24/7, for which I am 
very glad! Christopher, I am forever grateful for your patient support during ups and downs. I 





ACT, acceptance and commitment therapy 
ASN, Ane Sigrid Nygaard 
CI, confidence interval 
CPP, chronic pelvic pain 
EAU, European Association of Urology 
HSCL-25, Hopkins symptom check list-25 
IASP, The International Association for the Study of Pain  
IQR, inter quartile range 
MFE, Marthe Figenschau Eikedal 
NRS, numeric rating scale 
PT, physical therapy 
RCT, randomized controlled trial 
SD, standard deviation 
SHC, subjective health complaints 




List of papers 
I. Nygaard AS, Stedenfeldt M, Øian P, Haugstad GK. Characteristics of women with 
chronic pelvic pain referred to physiotherapy treatment after multidisciplinary 
assessment: a cross-sectional study. Scand J Pain, 2019; 19 (2): 355-364. Doi: 
10.1515/sjpain-2018-0308 
 
II. Nygaard AS, Rydningen M, Stedenfeldt M, Wojniusz S, Larsen M, Lindsetmo RO, 
Haugstad GK, Øian P. Group-based multimodal physical therapy in women with 
chronic pelvic pain: A randomized controlled trial. Acta Obstet Gynecol Scand. 
2020;00:1–10. Doi: 10.1111/aogs.13896  
 
III. Nygaard AS, Haugstad GK, Wilsgaard T, Øian P, Stedenfeldt M. Baseline pain 
characteristics predict change in pain intensity after physical therapy treatment in 
women with chronic pelvic pain. Secondary analysis of data from a randomized 







Background and aims: Chronic pelvic pain (CPP) is a common and complex condition, 
defined as pain perceived in structures related to the pelvis. Clinical guidelines recommend a 
bio-psycho-social management, with physical therapy included as one of multiple modalities. 
The ideal content and organization of such a management approach is unknown. The main 
aims of this PhD-thesis were 1) to describe the characteristics of women with CPP that were 
referred to physical therapy after evaluation at a tertiary hospital, 2) to compare the change in 
the mean pain intensity between women randomized to group-based multimodal physical 
therapy with women randomized to primary care physical therapy, and 3) to explore if 
selected pre-treatment characteristics were associated with change in pain intensity.  
Methods: Cross-sectional data of the participants were collected at baseline, and descriptive 
statistics applied. For comparison of the two interventions a randomized controlled trial 
(RCT) was conducted, and primary analyses performed with the Independent Samples T-test. 
Associations between baseline variables and change in pain intensity were investigated with a 
multivariable linear regression model. 
Results: The baseline data showed that women with CPP are a heterogeneous group with 
complex symptoms and high scores for both physical and psychological complaints. Women 
exposed to abuse have high scores related to analgesic use, sick leave, obstructed defecation, 
anxiety and subjective health complaints. Women with previous pelvic surgery report more 
analgesic use and sick leave, and lower pain intensity during intercourse, than those without 
previous surgery. In the RCT 26 women in the intervention group and 25 in the comparator 
group were available for data analysis. The group-difference in change in the mean pain 
intensity score was −1.2 (95% confidence interval, −2.3 to −0.2; p=0.027), favoring the 
intervention group. Pelvic pain for six years or more was associated with less pain reduction, 
and higher baseline pain intensity was associated with higher pain reduction after physical 
therapy treatment. 
Conclusions: Women with CPP represent a heterogeneous group, many with complex 
symptoms of both physical and psychological complaints. The reduction in the mean pain 
intensity from baseline to 12-months was significantly greater in the intervention group than 
in the comparator group, but the group-difference was small and the clinical relevance is 
uncertain. We hypothesize that pain duration and pain severity are of distinct importance in 
terms of treatment outcome. The results in the three papers implicate that further investigation 







Chronic pelvic pain (CPP) is a common and debilitating condition that has large individual 
and societal consequences.1-3 It is described as a complex condition, and defined as pain 
perceived in structures related to the pelvis.4  
 
Longstanding pain in the pelvic area has probably been a problem through long times, but the 
amount of research has been sparse, mainly focusing on organic causes of CPP. In 1991, a 
randomized controlled trial (RCT) showed positive effects of an integrated approach with 
attention on organic, psychological, dietary and environmental factors.5 Examination by a 
physical therapist was included, and the trial from 1991 represents the start of a new 
perspective on CPP-treatment. In the following decade, two non-randomized studies on 
psychosomatic physical therapy, a branch that equally addresses the physical and 
psychological dimensions of health, showed promising results.6, 7 
 
The amount of studies on CPP has increased dramatically since the early nineties. There has 
been a shift in clinical guideline recommendations over the last 10 years, and the current 
recommendations include physical therapy, patient education and active patient involvement 
in a bio-psycho-social management.4, 8 Systematic reviews of physical therapy and other non-
invasive treatments for CPP conducted during the last decade conclude that there are 
promising results for treatments that combine different modalities, but the evidence base is 
sparse and there is a need of more high quality knowledge both about the condition and about 
best management.9-12  
During the years 2008-2014 a group-based multimodal physical therapy program for patients 
with CPP was developed at the University Hospital of North Norway (UNN), as a cooperation 
between the Department of Physical Therapy and the Norwegian National Advisory Unit on 
Incontinence and Pelvic Floor Health. The contents of the multimodal program were largely 
inspired by studies on CPP showing positive results of integrated care as well as physical 
therapy treatments that combined bodily and cognitive approaches.5-7, 13 As the multimodal 
program at UNN seemed to be a successful treatment option, the need for a systematic 
evaluation emerged. The purpose of this thesis was to investigate the characteristics of the 
women that were referred for physical therapy after assessment at a tertiary hospital, to 
evaluate the effectiveness of a group-based multimodal physical therapy program, and to 
 
8  
explore if selected pre-treatment characteristics were associated with change in pain intensity 
after treatment. To the best of our knowledge this is the first RCT that evaluates a group-
based multimodal intervention that includes physical therapy for women with CPP.  
 
In the following chapter the theoretical and empirical background for the study is presented. 
First, the condition CPP is described in terms of definition, classification and epidemiology. 
The anatomy of the female pelvis is briefly reviewed, before the underlying causes and 
suggested pain mechanisms related to CPP is described. A review of the literature describing 
characteristics of women with CPP, and the evidence base for multimodal treatment that 
includes physical therapy is given. Based on this background, the overall aims of the thesis 
are presented and the methodology that was applied described. The main results are shortly 
presented, followed by an interpretation of the results and a thorough discussion of 
methodological aspects of the thesis. Finally, the conclusions based on our findings, clinical 




Chronic pelvic pain 
Definitions 
The core of the condition CPP is the experience of pain. The International Association for the 
Study of Pain (IASP) currently states that: 
 
“Pain is an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage.”14 
 
Pain is further described in terms of being acute or chronic. The current definition of chronic 
pain is: 
 
“Chronic pain is pain that lasts or recurs for longer than three months”15  
 
Various definitions have been used for CPP, but publications from the last decade seem to 
agree that CPP is pain in the pelvic area that has lasted for three to six months.16-18 In this 
thesis we apply the definition of CPP published by the European Association of Urology 
(EAU). This definition is centered on pain instead of being organ-centered, and thus in 
accordance with the IASP definition of pain as a subjective experience. The EAU states that:  
 
“Chronic pelvic pain is chronic or persistent pain perceived in structures related to 
the pelvis that has been continuous or recurrent for at least six months (…) and often 
associated with negative cognitive, behavioral, sexual, and emotional consequences, as 
well as with symptoms suggestive of lower urinary tract, sexual, bowel, pelvic floor, 
or gynecological dysfunction”.4 
 
The term ”perceived” indicates that the patient and clinician, to the best of their ability have 
localized the pain as being perceived in the specified anatomical pelvic area.4 The definition 
includes dyspareunia (pain during intercourse) and cyclic pain (eg. dysmenorrhea), if these 
are associated with negative cognitive, behavioral, sexual, and emotional consequences. 




Other frequently applied definitions of the condition is by the Royal College of Obstetricians 
and Gynecologists, that defines CPP as ”intermittent or constant pain in the lower abdomen or 
pelvis of a woman of at least six months in duration, not occurring exclusively with 
menstruation or intercourse and not associated with pregnancy”.18 The American College of 
Obstetricians and Gynecologists defines CPP as “pain originating from pelvic organs or 
structures and lasting >6 months”.17 
 
Underlying causes and pain mechanisms 
It is suggested that the condition CPP is best understood as an end symptom with multiple 
possible etiologies, each contributing to the result of chronic pain in the pelvic area.18, 19 The 
contributory etiologies may be associated with urological, gastrointestinal, musculoskeletal, 
gynecological, neurological or psychosocial conditions. In the following paragraphs the 
different pain mechanisms that are described in relation to the development of CPP will be 
presented based on the bio-psycho-social model. This model explain pain and disability, and 
a person’s perception of and response to it, as a dynamic interaction between multiple 
factors.19, 20, 21, 22 Different pain mechanisms may occur simultaneously, and the same 
presenting symptoms may have different underlying mechanisms.22 Figure 1 shows a bio-





Figure 1 A bio-psycho-social model of chronic pelvic pain.  
Adapted from Gatchel et al. 2007, Chimenti et al. 2018 and As-Sanie et al. 2020. 
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Biological pain mechanisms are closely related to processes in the peripheral and central 
nervous system, and to brain network activity. Three main categories of neural processes are 
described.23, 24, 25 Nociceptive processes are transmission of information of an actual or 
potentially tissue-damaging event. The information is encoded by nociceptors, which are 
high-threshold sensory receptors of the peripheral somatosensory nervous system.25 
Neuropathic and nociplastic processes involve the central nervous system and are especially 
related to chronic pain conditions.4 The main characteristics of the different mechanisms are 





Table 1 Neural pain processes  
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actual or potentially 
tissue-damaging 
event, encoded by 
nociceptors.25 
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In chronic pain conditions the different neural mechanisms often overlap, and nociplastic pain 
appear to play a prominent role.27 The neural plasticity, described as the possibility for 
structural changes in living tissues in the body, has been emphasized as a central feature in 
understanding chronic pain conditions.28 It has also been shown that the brain network 
activity in chronic pain is different than in acute pain. The brain activity connected to chronic 
pain seem to be more related to emotions.29 However, the exact mechanisms of the transition 
from acute to chronic pain are yet unknown. 
 
The interaction between psychosocial and biological factors, the mind and the body 
interaction, is getting more attention in relation to chronic pain conditions. Stress is a core 
condition of this interaction. The term “stress” applies both to dramatic stressful events, and 
to the many events of daily life that can elevate and sustain activities of physiological 
systems. Hormones associated with stress protect the body in the short run and promote 
adaptation by the process known as allostasis. In the long run allostatic load contributes to the 
wear and tear on the body and brain, and causes changes in the body that can lead to health-
damaging behaviors.30 Chronic pain can both be a result of other stressors and a factor that 
contributes to the total physiological burden, and thus to maintain a stress situation.21, 31 
 
Psychosocial factors involved in a chronic pain experience can be related both to emotions 
and cognitions.21 A persons pain beliefs develop during the lifetime as a result of an 
individual’s learning history and cover all aspects of the pain experience, such as the causes 
of pain, its prognosis, suitable treatments and possibility to control the pain. The meaning 
ascribed to pain by an individual can vary according to multiple factors.28 As shown in Figure 
1, social factors also include social network, work situation, exclusion, negative social 
feedback and cultural beliefs. 
 
The belief that pain means harm has been articulated through the fear avoidance model of 
chronic pain, and is supported by empirical evidence.32, 33 Pain catastrophizing can be defined 
as an exaggerated negative orientation toward actual or anticipated pain experiences, and is 
closely linked to fear avoidance beliefs. Such negative emotional factors, in addition to 
depression or anxiety, may contribute to the maintenance of a painful condition, and also 
influence treatment motivation and compliance with treatment recommendations.21, 34 For 
example, individuals experiencing pain avoid activities that they fear can evoke or aggravate 
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their pain.34, 35 Patients who are depressed and feel helpless may have little initiative to 
comply, and patients who are angry at the health care system are not likely to be motivated to 
respond to recommendations from health care professionals. 
 
The relationship between pain and the movement system has also received attention.22 It is 
complex and often highly variable between individuals. Pain can produce increased muscle 
contraction, tone, or trigger points, and lead to fear-avoidance behaviors resulting in disuse 
and disability.22 There is evidence that in most women with CPP the musculoskeletal system 
is compromised in different manners, either as postural changes or pelvic muscle contractures, 
or as the primary pain origin.36 
 
Classification 
A classification system aims to break down broad subjects into smaller, more manageable and 
specific parts, and thus is important both in research and for clinical management. For women 
with CPP, getting a diagnosis, or name, for the symptoms they experience, can provide them 
with a sense of being understood, as well as hope for relief.4 However, there are challenges 
connected to such classification as well. The consequence of putting the wrong “nametag” on 
a condition can be detrimental both in research- and clinical settings, and to implement one 
consistent classification system throughout the different medical specialties and health 
authorities is challenging. Trying to overcome this the EAU has developed a comprehensive 
classification system that incorporates other systems for describing chronic pain and CPP in 
particular.37 
 
In the EAU-classification, conditions where pain is associated with a specific disease or 
known inflammatory, infectious, ischemic, autoimmune, or neuropathic mechanisms are 
labeled as CPP with “well defined pathology”, or “non-pain syndromes”.4 In the cases where 
there is no obvious local pathology that may account for the pain, the term “chronic pelvic 
pain syndrome” is applied. In these cases pain is often the main symptom and pain as a 
disease process is considered to be the cause of the actual condition.  
 
When the pain can be localized to a specific organ the EAU further suggests that this should 
be acknowledged in the term used, for example “pelvic floor muscle pain syndrome” or 
“bladder pain syndrome”. However, if the pain is localized in multiple organs and no specific 
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diagnosis is shown, the term chronic pelvic pain syndrome should be used without adding the 
name of an end-organ.4 The EAU also states that in cases of CPP where treatment of well 
defined pathologies do not lead to expected pain relief, the same management approach as 
recommended for the chronic pelvic pain syndromes should be applied. Such cases can be 
when chronic pain develops after surgery, trauma or a known disease. 
 
The many dimensions related to the condition CPP are illustrated in the classification-table 
below (Table 2). The table is set up according to an axis system developed to assist clinicians 
in the process of describing and defining the main characteristics of pain syndromes. The axis 
refers to the body region (Axis I), organ system (Axis II), and end-organs involved (Axis III), 
the characteristics given in referrals (Axis IV), the temporal characteristics and patterns of 
occurrence, patients statement of pain intensity and duration (Axis V), pain character (Axis 
VI), associated somatic (Axis VII) and psychological symptoms (Axis VIII). 
  
Table 2 The European Association of Urology’s classification of chronic pelvic pain
 
(Hx = History; Ex = Examination; Ix = Investigation. The European Association of Urology 2019) 
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Prevalence and characteristics 
The reported prevalence of CPP varies largely, probably partly explained by different 
inclusion criteria and definitions used in studies. In two systematic reviews published in 2006 
and 2014 numbers between 2% and 27% were reported.2, 3 A Danish population study from 
2014 reported 15% prevalence, while a study from the United Kingdom in 2017 reported that 
11% of the female population had CPP.38, 39 Studies on other chronic pain conditions show 
that people often move “in and out” of longstanding pain conditions.40 This may also be the 
case for CPP, and thus contribute to unsure numbers of prevalence.  
 
CPP seems to affect women of all ages. Some studies have reported higher prevalence among 
women in reproductive age than older women, but the results are not consistent.1, 38 The 
condition occurs both in men and women, and many of the management approaches are 
probably relevant for men.4 However, in this thesis the focus is on females.  
 
Women with CPP report a number of symptoms in addition to pain in the pelvic area. As 
shown in Table 3 dyspareunia, dysmenorrhea, endometriosis, and psychological problems are 
frequently reported, and compared to women without CPP the reports of various health 
complaints are higher.38, 39, 41, 42 Some of the associated conditions occur as acute pain 
conditions that commonly are treated surgically, but may later develop to chronic pain, and 
some of the conditions described are of chronic nature.  
 
It has been shown that women with CPP have a specific pattern of posture, movement, muscle 
pathology and reduced body awareness compared to healthy controls.36, 43 Abuse exposure is 
found to be a factor that may predispose women to CPP,44 and the prevalence of sexual or 
physical abuse is reported to be up to 45% in women with CPP.45, 46 Previous surgeries in the 
pelvic area is reported by a large proportion, with numbers varying from 50% in a population 
based study to 90% of women with CPP recruited from a gynecological department.13, 39, 47 
 
The presence of pelvic pathology is identified as a factor that may predispose women to 
CPP.44 Higher pain intensities and longer pain durations are shown among women with other 
diagnosis in the pelvic area in addition to CPP.42  
	
Table 3 Population based studies on women with chronic pelvic pain 







Comparison to women without CPP 













Total: n= 2304 
 







<1 year: 19% 
1-5 years: 31% 
>5 years: 33% 
Unsure: 17% 
Mean VAS-score 
4.2 (SD = 2.6) 
Irritable bowel syndrome: 
38.5% 
 
Stress, ovarian cysts, 
endometriosis, cystitis, 
pelvic inflammatory 
disease, constipation, back 
pain, adhesions, 
appendicitis. 
Dysmenorrhea: 80% versus 60%  
Dyspareunia: 41% versus 14% 
 














Total n = 2088  











Constant pain: 10 
% 
Recurrent pain: 90 
% 
 
Fatigue, depression, sleep 




Two clusters identified: 1) 
little/no psychosocial 
distress, 2) high 
psychosocial distress. 
Multiple non-pain somatic symptoms: 40% 
versus 17% 
Significantly poorer scores for physical health 
and mental health 
 
Sleep problems: 29% versus 19% 
Fatigue: 56% versus 35% 










Total n = 1179  






Mean NRS: 4 
(IQR 2-6) 
 
48.5% had diagnosis of 
pelvic diseases. 
 
Irritable bowel syndrome 
(20%), vulvodynia (9%), 
endometriosis (8%). 
Dyspareunia: 7-35% versus 2-10% 
 
Diagnosis related to bowel, irritable bowel 
syndrome, bladder pain syndrome, vulvodynia 
and endometriosis significantly more prevalent 
in CPP. 
Previous pelvic surgery: 49% versus 31% 
CPP; chronic pelvic pain, IQR; inter quartile range, NRS; numeric rating scale, SD; standard deviation, VAS; visual analogue scale. 
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The female pelvis – anatomy and functions 
The female pelvis contains a number of structures, and serves important functions such as 
micturition, defecation, sexual function, reproduction, and mobility. The bones of the pelvic 
girdle serve as attachment points for trunk and lower limb muscles, as well as the internal 
pelvic muscles. The bony structures also protect the internal pelvic organs and support the 
weight of the upper body when sitting and transfer weight to lower extremities when standing 
and walking. The pelvic floor supports the pelvic organs, and together with the urethral and 
anal sphincter muscles it maintains continence, permit urination, defecation, intercourse and 
vaginal birth.48 The pelvic floor is arranged into overlapping layers of muscles and connective 
tissues, and consists of the perineal muscles (ischiocavernosus, bulbospongiosus and 
transversus perinea superficialis) and the levator ani muscle (iliococcygeus, the puborectalis 
and the pubococcygeus). The anal sphincter complex involving the internal and external anal 
sphincter muscles surrounds the anal canal (Figure 2).  
 
  
Figure 2 Muscles of the female pelvis  
(from the Textbook OpenStax Anatomy and Physiology May 201649) 
 
The visceral (intraperitoneal) organs in the female pelvis are the bladder, uterus, fallopian 
tubes and ovaries, intestines and rectum. The cervix, vagina and anus and pelvic floor muscles 
are extraperitoneal.  
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Pelvic structures are innervated by the somatic (T12-S5) and visceral (T10-S5) nervous 
systems, which are organized in complex anatomical and neurobiological networks. The 
primary nerves of the pelvis are the obturator nerve, the femoral nerve, the sciatic nerve and 
the pundenal nerve. The autonomic neuronal center of the pelvis is the hypogastric plexus, 
while the pudendal nerve is the major somatic nerve. An overview of the structures of the 




Figure 3 The female pelvis, sagittal view.  




Treatment of chronic pelvic pain 
When assessing women with signs of chronic pain in the pelvic area it is recommended to 
identify pathology that may cause ongoing tissue trauma, inflammation or infection in the 
early stages of investigations. If such conditions are excluded it is not recommended to 
perform further investigations for such causes.8, 17, 18 Aiming for precise classification, 
avoiding unnecessary investigations and starting effective management as soon as possible is 
emphasized as important.18 
 
Systematic reviews of non-surgical treatment of CPP in women show that a number of 
modalities are applied, such as pharmacological, psychological and complementary 
treatments, and physical therapy including electrotherapy, manual treatment, exercises or 
different forms for movement therapies. Some effect has been shown by several single 
treatment modalities, but the common conclusion in systematic reviews is that most studies 
had small samples, the modalities have not been tested in multiple studies, and the quality of 
the evidence is generally low.9-12, 50 Pharmacological modalities can be appropriate in some 
cases of long lasting pelvic pain, for instance to allow or improve compliance with other 
treatment modalities. Surgical and pharmacological modalities will, however, not be 
described further in this thesis. 
 
In this thesis the focus is on CPP-conditions with no well-recognized pathology, or CPP with 
well-recognized pathology that has not responded as expected to the recommended treatment. 
For these cases, the clinical guidelines of the EAU recommend a “holistic” approach, which is 
described as an approach that enhances biological, psychological, social and sexual factors, 
active patient involvement and provision of information that is responsive to the patient’s 
problems.8 Physical therapy is recommended as one component in a multimodal management, 
together with patient education.4 The EAU further recommends that management preferably 
should be undertaken in a multi-specialty and multi-disciplinary environment, and that those 
involved must have knowledge of peripheral and central pain mechanisms.4 The 
corresponding clinical guidelines from the Royal College of Obstetricians and Gynaecologists 
and the American College of Obstetricians also recommend a bio-psycho-social management 
based on principles from chronic pain in general.17, 18  
 
In the following paragraphs the treatment modalities physical therapy, patient education and 
psychological or cognitive therapies will be shortly described as applied in treatment of 
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chronic pain conditions. Further, the evidence base multimodal interventions for women with 
CPP combining physical therapy with one or several other modalities will be reviewed. 
 
Physical therapy 
Physical therapy is described as “services that develop, maintain and restore people’s 
maximum movement and functional ability, and help people improve their quality of life, 
looking at physical, psychological, emotional and social wellbeing”.51 Multiple techniques are 
available within physical therapy, such as exercises aiming to influence strength, endurance, 
flexibility, balance, posture or awareness, manual treatment of soft tissue or joints, patient-
related instruction, education or counseling, environmental interventions, and electro-
therapy.52 The rich “toolkit” gives physical therapists a good basis for practicing bio-psycho-
social treatment, and there exist a number of specialties within physical therapy.53 
 
Psychosomatic physical therapy is often applied in the management of patients with 
widespread or long lasting pain conditions.54, 55 The basic perspective in that specialty is that 
the mind and body is indivisible, and that a person total health is influenced both by 
biological, psychological and social strains.54, 56 The terms “body awareness”- and “mind and 
body interventions” are also applied for this kind of interventions, which is appropriate, as a 
key goal is to explore and experience how thoughts, emotions, attitude, movement and 
respiration are integrated and affect each other, and to integrate this new awareness into daily 
activities.13 54, 56 57 Psychosomatic interventions include a combination of treatment 
modalities, such as education, relaxation, massage, mindfulness, cognitive approaches and 
graded activity.55 Several branches are grounded on this theory. Examples relevant for this 
thesis are the “Norwegian psychomotor physical therapy”,54 “Mensendieck somatocognitive 
therapy”,13, 58 and “learning oriented physical therapy”.59, 60 Clinical trials on chronic pain 
conditions support the value of body awareness both in terms of pain-related and 
psychological benefits.61 
 
Manual techniques are commonly applied in the treatment of CPP; in the form of trigger point 
treatment, pelvic floor muscle exercises with or without biofeedback, myofascial release 
techniques, deep intra-vaginal massages, and electrotherapeutic modalities. Such techniques 
are suggested to increase the woman’s awareness of her pelvic floor muscles, in addition to 




Patient education is described as the process of giving information to patients that will alter 
their health behaviors or improve their health status.62 This can be done through a range of 
teaching techniques, as well as through the use of psychosocial and behavioral theories. 
 
The educational intervention “explain pain” was launched by Moseley and Butler in 2003, 
and has become a recognized and widely used approach.63, 64 The core objective of the 
intervention is to explain the key bio-psycho-social mechanisms that underpin pain, and to 
integrate the new understanding into pain- and function related beliefs, attitudes, behaviors, 
treatment, and lifestyle choices. Based on knowledge of neuroplasticity it is specifically 
emphasized that pain is a modifiable experience.64  
 
Current evidence supports the use of pain education for chronic musculoskeletal disorders in 
reducing pain and improving patient knowledge of pain.65  
 
Psychological treatments  
Psychological treatments applied in chronic pain aim to reduce disability and distress despite 
continuing pain.66 Such treatments focus on helping people to change behavior that maintains 
or worsens pain, disability, distress and catastrophic thinking. Cognitive behavioral therapy 
also directly addresses the thoughts and feelings that can be challenging for people with 
persistent pain. Evidence shows that addressing maladaptive psychosocial factors can 
maximize therapy effectiveness.22 
 
Acceptance and commitment therapy is one cognitive approach that focuses on behavior 
change rather than symptom reduction, and is often applied as a tool to help people accept 
present situations, set goals and commit to use available resources despite the challenges.67-69 
 
A systematic review of RCTs with psychological interventions for women with CPP that 
included only three studies, found that type of psychological intervention varied greatly. The 
most promising of the reviewed approaches was the Mensendieck somatocognitive therapy, 
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which combines a cognitive approach that includes working with dysfunctional thoughts, with 
physical therapy targeting awareness of posture, movement- and respiration patterns.50, 70 
Group-based versus individual treatment 
Physical therapy, and chronic pain management in general, can be organized as individual 
treatment or group-based interventions, or a combination of the two.51 Group therapy has 
been recommended as part of a multimodal treatment program, as it appears to have a positive 
effect on psychosocial outcomes.71 Benefits of participating in a group are related to the 
feeling of having similar problems as others, the feeling of belonging to the group, 
communication about the condition between group members, and the feeling of helping and 
supporting others.72 Group-based treatment can be time saving and cost efficient, and for 
physical therapy it has been shown that group treatment can be as effective in reducing pain 
as individual treatment.73  
 
Evidence base for multimodal treatment  
A literature search was conducted to identify trials on multimodal interventions that include 
physical therapy. The study population was limited to women aged 18 or more, diagnosed 
with CPP according to the EAU-definition, and studies published before 2005 were not 
included. Two RCTs, with rather small sample sizes, and three non-randomized trials were 
identified (Tables 4 and 5).13, 74-77 No RCTs that apply a multimodal intervention including 
physical therapy in a group setting were identified. 
 
As shown in Table 4 significant pain reduction and improved motor functions were shown 
after treatment with Mensendieck somatocognitive therapy combined with standard 
gynecological care, compared to gynecological care alone.13 Mensendieck somatocognitive 
therapy is a physical therapy treatment that combines exercises, manual treatment and 
cognitive techniques, focusing on exploration of movements and enhancement of body 
awareness.13, 78 In the study by Ariza-Mateos et al. (2018) a combination of patient education, 
graded exposure therapy and manual therapy was superior to manual therapy alone, and to 
none treatment, in terms of reducing fear-avoidance beliefs and improving pain interference. 




The results of the non-randomized studies indicate that positive changes can be obtained with 
multimodal treatment that includes physical therapy. However, the lack of control group 
makes it impossible to conclude whether the applied interventions are superior to any other 
intervention or not. Also, there seem to be some degree of spontaneous improvement in CPP, 
which also is a plausible explanation of the observed improvements.79 In the non-randomized 
trials the interventions are not clearly described, and it appears as if treatment modalities have 
been selected for each individual woman in a non-standardized manner. This might well be a 
reasonable procedure in a real-world clinical setting, but it makes it impossible to evaluate the 
effect of the single modalities. 
 
In studies that have investigated factors associated with treatment outcome in terms of change 
in pain intensity after treatment for CPP, psychological factors, pain characteristics, general 
health status and age have been identified as predictors.32, 76, 80 The same predictors are 
described for other chronic pain conditions,81 in addition to number of pain sites and pain 
duration.40, 82 However, both for CPP and other chronic pain conditions the strength and 
direction of the associations vary. 
Table 4 Randomized controlled trials of multimodal interventions including physical therapy for women with chronic pelvic pain 







n = 40 
Age: 33.3 
RCT IG: Mensendieck 
somatocognitive therapy 
(1hour/week) for 10 weeks + 
standard gynecological 
treatment (2 sessions)  
CG: Standard gynecological 




90 % after 
12 months 
Performance of functional tasks, SMTb (0-7a): 
12 weeks: Significant improvements in posture, active 
movements, gait, sitting and respiration in the IG, versus no 
significant improvements in the CG. 
12 months: Significant improvements from 12 weeks to 12 
months for active movements, gait and respiration in the IG, 
versus no significant improvements in the CG.  
Pain intensity - visual analogue scale (0-10a):  
12 weeks: IG 2.9 versus CG 6.2, significantly reduced from 
baseline in the IG only. 
12 months: IG 2.0 versus CG 6.0, significantly reduced from 











IG1: Pain education and graded 
exposure to fearful tasks 
selected by each woman (1x45 
minutes/week) + manual 
therapy (2x45 minutes/week) 
for 6 weeks 
IG2: Manual therapy 2x45 
minutes/week for 6 weeks 
CG: Booklet with CPP-
information  
100 % Fear-avoidance beliefs – physical activity (0-24a): 
6 weeks: IG1 significantly lower score than IG2 and CG (10.5 
versus 14.8 versus 17.3). 
12 weeks: IG1 significantly lower score than IG2 and CG (6.4 
versus 13.4 versus 19.6), and IG2 significantly lower scores 
than CG (13.4 versus 19.6). 
Brief pain inventory – interference (0-10a): 
12 weeks: IG1 significantly lower score than IG2 and CG (2.6 
versus 5.7 versus 5.1) 
Brief pain inventory - severity (0-10a): 
12 weeks: IG1 significantly lower score than CG (3.3 versus 
6.0). IG2 significantly lower score than CG (4.1 versus 6.0). 
aLower score indicate less bothers. bStandardized Mensendieck test, described in chapter four. 
RCT, randomized controlled trial; IG, intervention group; CG, comparator group 
 
Table 5 Non-randomized studies of multimodal interventions including physical therapy for women with chronic pelvic pain 
Author Study design Participants Intervention Adherence Main result 






n = 370 Pharmacotherapy, psychotherapy, 
physical therapy, or combinations of the 
three (n = 181 women), or surgical 
treatment (n = 189) 
62% non-
responders 
Pain: 46% improved, equal 
in the two groups. 
Depression: 32% improved. 
Modest improvements in 
both groups. 




n = 525 
Age: 34.3 
Interdisciplinary treatment at a specialist 
center. Patients chose between minimally 
invasive surgery, medical management 
and/or a pain program (pain education, 
physiotherapy and counseling). 
57% followed-
up at 1 year 
Pain severity (0-10):  
Baseline 6/10, 1 year 4/10, 
p<0.001 
Functional quality of life (0-
100a): Baseline 42, 1 year 29, 
p<0.001 
Physician or emergency 
visits (%): Baseline 96, 1 
year 47, p<0.001 











Medication management, weaning from 
habituating medications, 
physical/occupational therapy and 
individual, group and family 
psychotherapy  
Pain severity, pain-related 
sexual impairment and 
emotional symptoms 
improved significantly both 
in cases and controls. Greater 
sexual impairments in 
women with CPP both pre-
and post-treatment. 
aLower score indicate improvement. 




3 Aims of the study 
The overall aim of this thesis was to describe the characteristics of women with CPP that 
were referred to physical therapy after evaluation by specialist doctors at the tertiary hospital 
UNN, and to compare the change in mean pain intensity between women randomized to 
group-based multimodal physical therapy with women randomized to primary care physical 
therapy. 
 
The specific aims were:  
1) To describe the characteristics of women with CPP evaluated at the University 
Hospital of North Norway, and further referred to physical therapy (Paper I).  
2) To investigate if suggested risk factors such as history of abuse and previous 
surgeries in the pelvic area are frequently reported, and if women with and without 
these experiences report different subjective health status (Paper I). 
3) To compare changes in mean pain intensity between women randomized to group-
based multimodal physical therapy (intervention group) versus primary care physical 
therapy (comparator group) (Paper II). 
4) To explore if selected characteristics were associated with treatment outcome in 
terms of change in pain intensity at 12 months (Paper III).  
5) To explore baseline differences between women that dropped out of the study and 








4 Materials and methods 
Literature search 
The literature presented in this thesis was collected through searches in PubMed, Medline, 
PEDro and Cochrane Databases during the project period from 2015 to 2020. Searches were 
also made in the reference lists of relevant papers. Systematic searches were not performed, 
but the keywords of the thesis were included in the searches. Languages included were 
English and Norwegian. 
Key words applied were: pelvic pain, chronic pain, characteristics, women, multimodal 
treatment, physical therapy, women’s health, patient education, subjective health outcomes. 
 
Study design  
To address the multiple aims of the thesis, different study designs were applied. In Paper I a 
cross-sectional design was used, analyzing baseline data for all included women regardless of 
treatment group. In Paper II a parallel RCT design was applied to investigate group-
differences in change after an intervention period. In Paper III secondary analysis of the data 
collected in the RCT was performed for the whole group as one cohort.  
We chose to do a pragmatic RCT in Paper II. With this approach we aimed to test an 
intervention within a whole-spectrum clinical setting as seen in real-life clinical practice. This 
is in contrast to explanatory RCTs that seek to investigate how an intervention works, but 
then typically in well-defined and controlled settings with strict inclusion- and exclusion 
criteria.84, 85 An explanatory trial design is not suitable in a complex condition as CPP and 
with a complex intervention as in our study.86  
As a theoretical framework the bio-psycho-social model is applied. This is a widely accepted 
and practical applicable theory that meets the requirements of understanding pain as a highly 
subjective experience that is influenced by biological, psychological and social factors.20, 21, 22  
 
Participants 
The participants of all three papers were recruited from outpatient clinics at UNN. The main 
inclusion criterion was CPP with no well-known pathology identified, or CPP that could be 
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explained by a well-known pathology but had not responded as expected to the recommended 
treatment (Figure 4). Women referred to physical therapy following assessment and diagnosis 
by a gynecologist, urologist, and/or colorectal surgeon, with pain for a minimum of six 
months, aged 20-65 years, motivated to participate in a randomized trial, and able to speak 
and understand a Scandinavian language, were eligible. If malignancy or conditions requiring 
special medical attention were discovered, the women were referred to relevant follow-up, 
and not considered for study participation. 
 
The exclusion criteria were pregnancy, childbirth during the last year, drug addiction, serious 
psychiatric diagnosis, and previous treatment by the physical therapists at the intervention 
program. Women with intra-abdominal or pelvic surgery within the previous six months or 










The protocol for the study intervention was based on the EAU clinical guideline for CPP, 
taking a broad approach enhancing biological, psychological and social factors.4 The term 
multimodal was applied because of the concurrent application of therapeutic modalities with 
different mechanisms of action;25 including patient education,63, 65 explorative movement and 
body awareness therapy,54, 61 and the cognitive approach ACT.68 The overall aim was to 
facilitate change in terms of reduced pain and improved daily function, and this was sought 
through increasing knowledge of pain and its effect on body and mind, challenge habits of 
avoidance related to fear of pain, and to give new positive movement experiences. 
The study intervention consisted of a total of 16 treatment-days during one year. The first 
session lasted for 10-days, and was followed by two-day sessions after three, six and 12 
months (Figure 5). The rationale for the long duration was based on theories of behavioral 
change, emphasizing that it takes time to integrate new experiences into daily routines and to 
obtain lasting changes.65 The intervention was run in the city of Tromsø, and participants 
from other places stayed in a hotel or other suitable accommodation during the sessions.  
 
The intervention was group-based with between five and 10 women in each group. Each 
participant had an individual physical therapy assessment at the start and the end of the 
program (Figure 5). The structure of the intervention was predetermined with a detailed 
schedule for all sessions (Appendix 1), but small adjustments could be done according to the 
specific group's needs. Every day lasted from 8.30 to 15.00 with a combination of movement 
and body awareness therapy, patient education, group discussions and reflections. The 
participants were provided with a workbook that included both short informative notes and 
reflection tasks to work with both during and between the sessions. 
 
The study intervention was run by three physical therapists with competence in 
psychosomatic physical therapy, women’s health and chronic pain management. A 




Figure 5 Timeline of the multimodal intervention  
 
Movement and body awareness therapy 
The explorative movement and body awareness therapy combined elements from the 
Norwegian psychomotor physical therapy,54 learning oriented physical therapy59, 60 and 
Mensendieck somatocognitive therapy, three different branches within the concept of body 
awareness therapy.13, 58 The purpose was to enhance the body and mind interaction and to 
increase the women’s awareness about own body reactions and resources.7, 54, 61 Through 
functional movement tasks the women were challenged to explore flexibility, balance, 
respiration, postural stability, muscle tension and relaxation, and to reflect about how these 
functions are influenced by each other and by physical, emotional or social strain.78 Individual 
guidance in adjusted movement tasks aimed to provide positive movement experiences, in 
order to gradually reduce the expectation of pain with movements.33 There was shifting focus 
between tasks involving the whole body and exercises focusing specifically on the pelvic 
area, such as practicing to stand firmly on both legs, being aware of how the abdomen move 
during respiration or recognition of tension versus relaxation when performing pelvic floor 
muscle exercises. Two daily lessons of movement therapy were held in a small gym, and one 
in a heated pool.87 
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A Standardized Mensendieck Test of functional movements was integrated in the program, 
and conducted both at the start and end of the 12-month intervention.88 The test was 
videotaped in order for the participants to review their performances at the last day of the 
program. The purpose of this is to facilitate reflection and awareness of the changes that have 
or have not occurred during treatment. In this study the test was also included as one of the 
outcome measures and therefore videotaped by the data collector both at inclusion and at 
posttests. The women that were randomized to the intervention group watched the video 
together with the physical therapist at the last session of the treatment. 
 
Patient education 
Lectures on topics related to living with CPP, both focusing on biological and psychosocial 
factors, were given in twice daily during the first 10-days session. Largely based on the theory 
of “Explain pain” that was described in chapter 2, the purpose was to improve the participants 
understanding of pain mechanisms, with special focus on why pain can persist despite lack of 
objective findings and after the expected time for tissue healing.63, 65 Further, the lectures 
aimed to influence the women’s pain beliefs, introduce new perspectives about possibilities to 
control the pain, for changing focus and setting realistic goals for changes. Group discussions 
and individual tasks related to the topics were part of the educational sessions. The exact 
topics that were discussed are shown in the intervention schedule (Appendix 1).  
 
Acceptance and Commitment Therapy 
ACT was included in the multimodal intervention as a tool to help the women to accept that 
the pain is present, set goals and commit to use available resources despite the pain.67-69 ACT 
was introduced in the lectures and incorporated both in the practical and theoretical sessions. 
The reflection tasks in the workbook were based on techniques applied in ACT. 




Women randomized to the comparator group were referred for physical therapy in primary 
health care, which is the usual procedure when a medical specialist recommends physical 
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therapy. The participants were given information about physical therapists near their home 
with competence in women's health, and alongside the referral they received an information 
letter for the therapist (Appendix 3). There was no standardization of the contents of the 
comparator treatment, other than that the therapists were asked to provide treatment according 
to own academic competence and in consultation with the woman. The deductibles of 
physical therapy treatment were refunded, and women that still needed treatment were offered 
participation in the group-based intervention after study completion. 
 
For participants in both groups, a website with information about CPP was available. All 




The trial was conducted at the Norwegian National Advisory Unit on Incontinence and Pelvic 
Floor Health at UNN. Baseline data were collected at the Physiotherapy Outpatient Clinic at 
the time of inclusion, before randomization. Baseline data collection took place between 
March 2015 and November 2016. All outcomes were registered again 12 months after start of 
the study intervention or after being referred to primary care physical therapy. Women who 
did not manage to travel to the hospital for the post-test due to practical reasons were 
contacted by phone and mail. Two physical therapists (ASN and MFE) performed all the 
baseline and follow-up tests.  
 
Outcome measures 
Demographic information and information about medical history were collected at baseline 
using a semi-structured interview. This included information about age, body mass index, 
smoking, number of children, civil status, education, work status, pain duration, main pain 
site, use of analgesics, previous treatment, previous surgeries, other diagnosis and abuse 
exposure (physical, psychological, or sexual). Appendix 4 shows the interview guide that was 
applied at baseline. 
 
After 12 months a modified interview guide were used to collect information about changes 
in demographic or medical information during the study period. In addition, information 
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about number of consultations and type of treatment were registered. Appendix 5 show the 
interview guide applied at 12 months. 
 
Pelvic pain intensity (Papers I, II and III) 
Information about baseline pain intensity was collected and presented in Paper I. Change in 
mean pain intensity from baseline to 12 months follow-up was the primary outcome measure 
in Papers II and III. 
Pelvic pain intensity was assessed using a numerical rating scale (NRS), an eleven point box 
scale in which zero represents no pain and 10 represents pain as bad as it can be.89 The 
participants were asked to rate their mean, worst and least pain intensity during the last seven 
days. There was also a rubric for the participants to state if pain in the last week was worse, 
better, or unchanged compared to the previous month. Information about pain intensities was 
registered by mail at three and six months, in addition to the registrations at baseline and 12 
months. The NRS has shown good sensitivity and validity.89, 90 According to Williamson and 
Hoggart (2003) the NRS is as a measure that provides parametric data.89 
  
Movement patterns (Paper II) 
Movement patterns were assessed with the Standardized Mensendieck test, which evaluates 
performance of standing and sitting posture, active movements, gait and respiration patterns, 
according to criteria based on functional anatomy.88 The test was video recorded before a 
blinded physical therapist scored the five domains on a scale from zero to seven (0=least 
optimal, 7=optimal). The Standardized Mensendieck test has been validated in a sample of 
Norwegian women with chronic pelvic pain.88 
 
As described above the test was included as a part of the study intervention in addition to 
being applied as an outcome measure. 
 
Sexual function (Papers I and II) 
Information about sexual function was recorded using a modified self-reported questionnaire 
originally developed by Træen et al.91 The questionnaire comprised four questions. First the 
women were asked whether they were sexually active, with answers reported as “yes” or 
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“no”. If they answered affirmatively they were asked if they had experienced lack of sexual 
desire or dyspareunia over the past 12 months. Answers were reported as “Yes” (“all the 
time,” “almost all the time,” and “quite often”) or “No” (“quite rarely” or “never”). In 
addition the women were asked to register the intensity of dyspareunia on a NRS (0-10). The 
questionnaire, which has not been validated, is enclosed in Appendix 6. 
 
Subjective health complaints (Papers I and II) 
The Subjective Health Complaints (SHC) questionnaire was used to register common somatic 
and psychological health complaints during the last 30 days.92 The 29-item list consists of 
complaints in the categories musculoskeletal pain, pseudoneurology, gastrointestinal 
problems, allergy, and flu. Severity of each complaint is rated on a 4-point Likert scale 
(0=none, 1=some, 2=much, 3=severe). The SHC questionnaire is known to be a reliable 
measure of SHC.92 
 
In Paper I the proportion of women who reported any complaints (score 1–3) within each of 
the five categories was calculated. In addition, the proportion of women reporting each of the 
29 single complaints (score 1–3) and the proportion of women reporting severe complaints 
within the 29 items (score 3), were calculated.92  
 
In Paper II the total score of SHC was reported on a continuous scale from 0-87 (higher 
scores indicate more complaints).92 
 
Symptoms of anxiety and depression (Papers I, II and III) 
Common symptoms of anxiety and depression were measured using the Hopkins Symptom 
Checklist (HSCL-25).93, 94 The respondents indicated the extent to which they had 
experienced any of 25 different symptoms of anxiety and depression over the last 14 days 
using a four-point Likert scale ranging from 1-4 (1=not at all, 2=a little, 3=quite a bit, 
4=extremely). The HSCL-25 is known to be a reliable measure among Norwegian women, 
and its validity has been shown in a Swedish population.95, 96 
 
In Paper I separate mean scores for anxiety and depression items were calculated. A cut off 
point of 1.75 was used to distinguish women with and without psychiatric symptoms, and the 
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dichotomized data were presented.95  
 
In Papers II and III the total score was reported on a continuous scale with possible scores 
ranging from 1-4 (higher score indicating more severe symptoms). 
 
Urinary incontinence (Papers I and II) 
Urinary incontinence was defined as “the complaint of involuntary leakage of urine” and 
documented by the self-administered questionnaire ICIQ-UI SF.97 Scores range from 0 to 21, 
and values of one or higher indicate urinary incontinence. The questionnaire is validated and 
the Norwegian version is found adequate for use after linguistic validation.98, 99 
 
In Paper I the dichotomized scores were used to differentiate between women reporting and 
not reporting UI, and in Paper II both the dichotomized and continuous scores were reported. 
 
Anal incontinence (Papers I and II) 
Information about anal incontinence, defined as involuntary passage of fecal material and/or 
flatus100,  was collected using the validated St. Marks interview score.101 The score gives 
information about type (gas, liquid, solid) and frequency of anal incontinence, its impact on 
daily life, the need to wear a pad or plug, the use of constipating medication, and the lack of 
ability to defer defecation for 15 minutes.101 Scores range from 0 to 24, and scores zero to 
three indicate no anal incontinence while scores between four and 24 indicate anal 
incontinence.102, 103  
In Paper I the dichotomized scores were reported to differentiate between women reporting 
and not reporting anal incontinence, and in Paper II both the dichotomized and continuous 
scores were reported. 
 
Obstructed defecation 
To record information about obstructed defecation symptoms a five-item score developed and 
validated by Renzi et al. was used.104 Each item is graded from zero to five with a maximum 
total score of 25, and the optimal cutoff point to discriminate between healthy participants and 
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patients with and without obstructed defecation symptoms is found to be a score of nine 
(≤8=no obstructed defecation symptoms and ≥9= obstructed defecation symptoms).104 
 
In Paper I the dichotomized scores were reported to differentiate between women reporting 
and not reporting obstructed defecation symptoms, and in Paper II both the dichotomized 
and continuous scores were reported. 
 
Sample size calculation 
The sample size was calculated based on the results from an RCT conducted on women with 
CPP that applied an intervention similar to the one in this study, though it was individually 
delivered. The aforementioned study showed a change of 2.2 on the NRS for mean pain 
intensity between the groups after three months13 which indicated a difference of one standard 
deviation (SD) in the change. Based on these assumptions, the effect size was estimated as 
“1”. With a significance level of 0.05, a power of 90%, and an estimated dropout rate of 30%, 
33 women should be included in each group. 
 
Randomization and blinding 
The randomization database was administered by the Clinical Research Department at the 
hospital, and available only for the primary researcher and the project leader. Randomization 
with alternating block sizes of four and six were applied. A nurse at the Pelvic Floor Center 
administered referrals to treatment groups. 
Because of the nature of the intervention and comparator group, the participants and physical 
therapists involved could not be blinded. The person that scored the videos of the 
Standardized Mensendieck Test was blinded to group assignment and to time of data 
collection (baseline or 12 months). 
 
Statistical analysis 
All statistical analyses were conducted using IBM SPSS Statistics for Macintosh, versions 25 
and 26.105 The level of statistical significance was set to p<0.05.  
 
In all three papers descriptive statistics were presented with mean and SD or median and 
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interquartile range (IQR) for the continuous variables, and frequencies and percentages for the 
categorical variables. 
Paper I: To investigate differences in current subjective health status between women with 
and without a history of abuse and with and without pelvic surgery, the variables “sick leave 
≥12 weeks last year,” “use of analgesics weekly in the last month,” “pelvic pain intensity,” 
“dyspareunia”, “urinary incontinence”, “anal incontinence”, “obstructed defecation 
syndrome”, “number of any SHC,” “number of severe SHC,” and “HSCL-25 score above 
1.75” (included subscales for anxiety and depression) were tested separately with bivariate 
tests. For continuous variables the independent samples t-tests or Mann Whiney U-tests were 
used as appropriate, and for categorical variables the Pearson Chi-square test for 
independence was used. 
 
Paper II: For continuous data, the independent samples t-test or Mann-Whitney U-test was 
used for primary analyses of group-differences in the change in the groups from baseline to 
12 months. The assumptions for parametric tests of normal distribution of residuals and 
equality of variances were checked before analyzing the data.106, 107 For the categorical 
variables changes in the number of women reporting problems were described. Sensitivity 
analysis of the primary outcome was performed with a linear regression model adjusted for 
the baseline value. The statistical analyses followed the intention-to-treat approach.  
In case of missing data on sub-items of the secondary outcome measures, averages of the 
available responses were used.108 Outcome measures with more than 10% of missing items 
were not included in analyses. 
Paper III: The potential associations between the selected pretreatment characteristics and 
change in mean pain intensity were first assessed one by one in a linear regression model, 
adjusted for age and treatment group. The variables with strongest association (p<0.10) with 
the primary outcome were further included in a multivariable linear regression model with 
backward selection, adjusted for age and treatment group. The normality and 
homoscedasticity assumptions for the multivariable linear regression model were assessed by 
visual inspection of the residuals. Estimates of association were presented as regression 
coefficients with 95% confidence intervals (CI). For continuous variables, the regression 




Ethical considerations, trial registration and funding 
This study was conducted in accordance with the principles of the Declaration of Helsinki. 
Written and oral study information was provided to the participants, and the informed consent 
forms were signed. The study was approved by the Regional Committee for Medical and 
Health Research Ethics North (18.09.2014 2014/1398, Appendix 7) and by the Institutional 
Review Board at the University Hospital of North Norway (0444 / 24.02.2015). The trial was 
registered at clinicaltrials.gov (NCT02356796, February 5, 2015) and reported in accordance 
with the CONSORT statement.109 
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In this chapter a summary of the main results will be given. The detailed results are found in 
the enclosed papers.  
	
Participant flow, dropouts and adherence  
A total of 108 women were considered for study participation. Sixty-two (57%) of these 
women gave consent to participate in the study and were included, 31 (29%) declined to 
participate, and 15 (14%) did not meet the inclusion criteria. Excluded participants were 
offered a referral to regular physical therapy treatment. The participant flow through the 
papers is shown in Figure 6.  
 
Among the 62 randomized women, six in the intervention group and five in the comparator 
group, dropped out of the study before the 12-months analysis. Reasons for dropping out were 
withdrawal (n=5), lost to follow-up (n=4) and missing data on the primary outcome at 12 
months (n=2).  
 
The majority of the women in the intervention group attended all the four sessions. One 
woman attended only for the first 10-days session, and seven attended 12-14 days of the total 
16 treatment days (median 16, IQR 2). In the comparator group the median number of 
physical therapy consultations was 14 (IQR 29). One woman did not receive any physical 
therapy during the 12 months from baseline data collection to post-test.  
 
Table 6 shows the main baseline characteristics regarding demography, pain status and 
medical history of the participants in each of the three papers. Detailed descriptions of the 






Figure 6 Participant flow through the study 








































Assessed for eligibility 
(n = 108) 
Included in study (n = 62) 
 
PAPER I 
Allocated to the study intervention (n=32) 
 
Received allocated intervention (n=28) 
 
Did not receive allocated intervention (n=4) 
Excluded before 
inclusion (n = 46) 
- Not meeting inclusion 
criteria (n = 15) 
- Refused to participate 


















Allocated to comparator treatment (n=30) 
 
Received allocated intervention (n=29) 
 
Did not receive allocated intervention (n=1) 
Analyzed at 12 months (n = 26) 
 




Discontinued intervention (n=4) 
 
Lost to follow-up (n=2) 
 
 
Discontinued intervention (n=1)  
 
Lost to follow-up (n=2) 
 
Analyzed (n = 25) 
 
Excluded from analysis due to missing 12-
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Table 6 The main baseline characteristics of the participants in Papers I, II and III 





(n = 26) 
Comparator 
group  









1.6 (1.4) 2.0 (1.5) 1.3 (1.2) 1.6 (1.4) 1.6 (1.4) 
Higher educationa,  
n (%) 
28 (45.2) 11 (42.3) 14 (56.0) 25 (50.0) 3 (25.0) 
Active in work of 
studies,  
n (%) 
34 (54.8) 13 (50.0) 15 (60.0) 28 (56.0)  
Sick leave >12 weeks 
last year, n (%) 
18 (32.0)b 9 (36.0) 6 (27.3) 15 (32.6) 3 (30.0) 
Pelvic pain intensity 
last week (NRS 0-10),  
mean (SD) 
4.5 (2.4) 4.7 (2.0) 4.5 (2.8) 4.6 (2.4) 3.8 (2.5) 
Duration of pelvic 
pain, n (%): 
     
  1 - 4 years 19 (30.6) 9 (34.6) 7 (28.0) 16 (32.0) 3 (27.3) 
  4-10 years 17 (27.5) 8 (30.8) 7 (28.0) 15 (30.0) 2 (18.2) 
  > 10 years 26 (41.9) 9 (34.6) 11 (44.0) 19 (38.0) 6 (54-5) 
Previous abdominal or 
pelvic surgery, n (%) 
44 (71.0) 18 (72.0) 15 (60.0) 32 (65.3) 9 (81.8) 
History of abuse,  
n (%) 
31 (50.0) 12 (46.2) 15 (60.0) 26 (52.0) 4 (36.4) 
aCompleted ≥1 year of University College or University. bFive missing at baseline.  




The results showed that women with CPP have complex symptoms and high scores for both 
physical and psychological complaints, including reduced sexual desire and pain during 
intercourse. The mean pain intensity at baseline was reported to be approximately the same as 
that experienced over the last four weeks by 49 women (79%). The majority (n = 47, 76%) 
also reported that they had experienced constant pain during the last week.  
Thirty-one (50%) of the women reported events perceived as abuse of a physical, 
psychological or sexual nature. Compared to women not exposed to abuse, a significantly 
larger proportion of the women exposed to abuse reported use of analgesics (61% versus 
35%, p = 0.04), sick leave >12 weeks (56% versus 14%, p = 0.005), anxiety scores above cut-
off (56% versus 21%, p = 0.009) and obstructed defecation syndrome score above cut-off 
(48% versus 19%, p = 0.02). They also reported a higher median number of total subjective 
health complaints (14 versus 11, p = 0.02), than women not exposed to abuse (Table 2 in 
Paper I). 
 
Forty-four (71%) women reported a previous intra-abdominal, vaginal or anal surgery, with a 
range from 1 to 10 surgeries for each of these women. Women reporting previous surgery 
used more analgesics (p=0.04), reported more sick leave (p=0.02), and less dyspareunia 
(p=0.008) than those not reporting surgery (Table 3, Paper I). 
 
Paper II 
The results of the RCT showed that the mean change in the primary outcome was -1.8 (-2.6 to 
-1.0) in the intervention group and -0.5 (95% CI -1.3 to 0.3) in the comparator group. Among 
the women in the intervention group, 19 reported improvement whereas four reported no 
change and three reported worsening in mean pain intensity. In the comparator group 17 
reported improvement, three reported no change and five reported worsening. The group-





Figure 7 Mean pelvic pain intensity at different time points for the two groups 
 
The intervention group showed greater improvements for respiratory patterns assessed with 
the Standardized Mensendieck test (mean difference 0.9, 95% confidence interval 0.2-1.6, p = 
0.015) and for pain-related fear of movements assessed with the Tampa Scale of 
kinesiophobia (mean difference 2.9, 95% confidence interval -5.5 to -0.3, p = 0.032). There 




Among the four baseline variables that were included in the multivariable regression analysis 
the variables duration of pain ≥6 years and mean pain intensity at baseline were identified as 
significant predictors of change in pain intensity after PT-treatment. The regression 
coefficient for duration of six years or more was 1.3 (95% CI 0.3 to 2.4), meaning that 
compared to the group with shorter duration than six years the mean change in pain intensity 
was 1.3 points higher (=worse) in the group with longest duration after PT treatment. For pain 
intensity the regression coefficient was -0.6 (95% CI -1.1 to -0.1), meaning that for every 
standard deviation (SD = 2.4) increase of baseline pain intensity the changes in pain after 12 
































The variable main pain site in the pelvic area (yes/no) was not included in the regression 
analysis due to few participants in one of the categories (n=5), but we observed that none of 
these five women reported pain reduction after physical therapy treatment.  
 
Observations of the baseline data for the women that dropped out of the study showed that 
they were more likely to have a body mass index of 25 or higher. A larger proportion had 
lower education, and 55% (n=6) were on sick leave at the time of data collection compared to 
12 % (n=6) of the women that did not drop out. A larger proportion of the women that 
dropped out had used analgesics weekly the last month, reported main pain other sites than in 
the pelvis or had a higher number of previous surgeries. They also had a higher mean score on 





Summary of main findings 
The aims of this thesis were to obtain knowledge of the characteristics of women with CPP 
referred to physical therapy after being cleared for non-malignancy or other specific therapy 
at a tertiary hospital, and to compare the effectiveness of a group-based multimodal treatment 
with primary care physical therapy. Additionally, we aimed to investigate if selected baseline 
characteristics were associated with treatment. 
 
We found that the study population represented a heterogeneous group of women with a 
range of different histories and health statuses. The reduction of the mean pain intensity from 
baseline to 12-months was significantly greater in the intervention group than in the 
comparator group, but the difference in the change between the groups was less than expected 
and the clinical relevance of the results is uncertain. Further, women with the longest pain 
durations were less likely to obtain reduced pain intensity after physical therapy treatment, 
and higher baseline pain intensity was associated with larger reduction in pain after treatment. 
 
In the following chapter these results will be discussed more thoroughly. The results of the 
single papers will be seen in relation to each other, and be discussed in light of the theory and 
evidence presented in the background chapter.  
 
Interpretation of the results 
Paper I 
The analysis of the baseline data of the 62 women included in this study confirmed previous 
descriptions of women with CPP in terms of long pain duration, multiple associated health 
complaints and multiple treatment alternatives tested.1, 41, 42, 44, 110 The health histories and the 
magnitude of current health complaints varied among the women. This heterogeneity is 
considered to be an essential characteristic of the group, and important both for the 
interpretation of the treatment results in the present study, for clinical practice and in planning 
of future research. 
The mean pelvic pain intensity reported at baseline was 4.7 on the NRS-scale. This is in 
accordance with the pain intensities previously reported in population-based studies of 
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women with CPP,38, 39, 41 and slightly lower than reported in studies conducted in clinical 
settings.43, 46 An important observation is that the standard deviation of the mean pain 
intensity was 2.4, reflecting large variations in baseline pain between the women in the group. 
The majority of women reported unchanged mean pain intensity during the last month, 
indicating that the numbers reported are representative for their “usual” pain. 
The prevalence of sexual dysfunction, urinary incontinence, anal incontinence and obstipation 
were higher among the women in our study than reported in the general population.111, 112, 113 
The majority of the participants were sexually active, and about two thirds of these women 
reported reduced desire and dyspareunia. These numbers are in the upper tier compared to 
previous reports of dyspareunia among women with CPP, where the prevalence of 
dyspareunia vary between 6% and 75%.4, 42, 38, 43 The severity of incontinences and 
obstipation was low for most women, but for the few women with severe problems such 
dysfunctions are important to reveal. No comparable numbers have been found for other 
chronic pain patients, but it is likely that these pelvic dysfunctions are more prominent in 
women with CPP and thus especially important to address during assessment and treatment.  
 
Surgery in the abdominal or pelvic area was reported by almost three quarters of the women 
in the present study, with a total of 116 surgeries reported among those. Compared to 
previous studies on CPP this number appears higher, although direct comparison is not 
possible due to differing reporting methods and inclusion criteria.13, 47 Women with previous 
surgery had been more on sick leave and used significantly more analgesics than those 
without. Notably, they also reported lower mean pain intensity during intercourse than 
women without previous surgery. This may be due to more analgesic use, or indicate that in 
some cases surgery have alleviated pain from local pathologies and thereby also led to less 
dyspareunia. In contrast to other reports, we did not find associations between having had a 
surgery and scores of anxiety, depression, or other health complaints.1, 44 The heterogeneity 
among the women in the study sample both regarding history and present health status may be 
an explanation of the lack of associations shown. 
 
Abuse has been identified as a potential risk factor for CPP.44 Fifty percent of the women 
reported that they had been exposed to physical, psychological or sexual abuse. The high 
number is in line with the findings in a survey of 713 women with CPP recruited from an 
American pelvic pain clinic, with 46% reporting abuse exposure.45 Studies that report only 
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sexual abuse show a prevalence of 15-25% among women with CPP, equivalent to other 
patient groups.114-116 The reports of abuse appear to be high compared to the general female 
population, but cannot be directly compared as different definitions and data collection 
methods have been used. Women with a history of bullying or abuse have been shown to have 
poorer scores on both somatic and psychological health measures,117 and several reports 
indicate that exposure to abuse of any kind can lead to a higher risk of poor health later in 
life.45, 115, 116, 118 This was supported by our study, as the women reporting abuse also reported 
significantly poorer scores of other health outcomes such as anxiety, obstructed defecation 
and total subjective health complaints. 
 
Paper II 
To our knowledge, the RCT conducted here is the first that compares a group-based treatment 
consisting of body awareness therapy, patient education, and cognitive techniques with 
primary care physical therapy for women with CPP. The study intervention had not 
previously been evaluated systematically and never been compared to other treatments, hence, 
we did not know which treatment approach would give the best result for the participants. The 
results of the RCT showed larger improvements in pain intensity, respiratory patterns and 
pain-related fear of movements among the participants in the multimodal group based 
intervention than among those referred to primary care physical therapy.  
 
The differences in changes between the two study groups were small, possibly explained by 
the heterogeneity described in Paper I. The varying results of both study groups may indicate 
that women with CPP benefit from different interventions, supporting further investigations 
of subgroups within the condition.4, 12 This is supported by the findings in a recently 
published study of Norwegian patients with a range of chronic pain conditions, concluding 
that investigation of subgroups are necessary to improve treatment outcome.119 The varying 
change in pain intensity in the intervention group contrasts with the results by Haugstad et al., 
where only one of the 19 women in the somatocognitive therapy group reported unchanged 
pain, and the rest of the group improved.13 This can be due to differences between the 
samples in the two studies, but it can also reflect different interventions and study designs. 
The intervention in Haugstad et al. was individually delivered, and contained manual soft-
tissue treatment in addition to body awareness exercises and cognitive strategies. Group-based 
interventions can provide a feeling of belonging to a group, exchange of valuable experiences 
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with others with a similar condition, and depending on the setting and organization it can be 
time saving and cost efficient.71, 72, 73 However, a group-setting may be challenging for some 
patients as well,73 and for those an individual approach can be more suited. Also, manual 
techniques are shown effective for pain reduction in CPP, and may provide extra benefits for 
some women.12 
 
In our study we found a group-difference in change of pain of 1.2, while in Haugstad et al. it 
was 2.2. In the latter study the intervention was compared to two consultations with standard 
gynecological care consisting of advice and medication, while in our study the comparator 
group received physical therapy consisting of pelvic floor muscle training, general exercises, 
relaxation exercises and soft tissue treatment alone or in combination. Half of the women in 
our study also reported dialogue with the therapist as a part of the treatment. This shows that 
physical therapy as administered in primary care in many cases also addresses the multiple 
factors of CPP. In the RCT published in 2019 by Ariza-Mateos et al. the comparator group 
received physical therapy, and the results showed a difference in pain reduction of 1.1. This is 
similar to what we found, and confirms the explanation of smaller group-differences when 
both groups receive physical therapy.83 
 
The multimodal treatment aimed to give new positive movement experiences, to increase the 
knowledge of pain and its effect on body and mind as well as challenge habits of avoidance 
related to fear of pain. We argue that although the group differences were smaller than 
expected, the statistically significant greater improvements in pain, respiratory patterns and 
pain-related fear of movements in the intervention group support the hypothesis that a group-
based multimodal approach is suitable for women with the multifaceted condition CPP. The 
complex characteristics described in Paper I and the multiple pain mechanisms are also 
arguments for the application of a broad management that addresses the multiple mechanisms 
assumed to be involved.4 The perspectives provided in ACT may be especially helpful in 
dealing with a complex condition like CPP. In many cases the women may feel insecure 
regarding the condition and the prognosis, and a structured method to accept not only the 
pain, but also to accept the insecurity related to the pain condition, can be central in a process 
of change.67, 69 
 
Respiration patterns are described as closely linked to the ability to relax and to body 
awareness, and the findings of improved respiration patterns can thus be related to the 
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relaxation techniques and body awareness in the study intervention.120 New experiences 
through the movement therapy combined with pain education can enhance the feeling of 
control of the pain, and thus reduce the fear of pain related to movements or activities.28, 35, 32 
The greater improvements in respiratory patterns and pain-related fear of movement shown in 
the intervention group corroborate with the previous results presented by Haugstad et al.13 and 
Ariza-Mateos et al.83 
 
Surprisingly, we found no statistically significant changes in the other outcome measures that 
were included in the RCT. Both groups obtained an improvement in health related quality of 
life equivalent to estimated minimal important change.121 However, there were no group 
differences in the change. For symptoms of anxiety and depression, dyspareunia, reduced 
sexual desire and obstructed defecation the improvements were not statistically significant. 
The proportions reporting problems with urinary or anal incontinence remained almost 
unchanged during the intervention period. However, the numbers were small and this study 
was not powered to detect differences in improvement in the multiple secondary outcomes. 
 
The greatest reduction in mean pain intensity in the intervention group was observed between 
six and 12 months. In the comparator group the pain reduction did not change after the first 
three months. The continued pain reduction might reflect that a pre-planned program designed 
to last for 12 months entails positive factors such as the feeling of being in a system and 
predictability. Considering the theory that chronic pain also is sustained by some types of 
behaviors, these results are in line with behavioral change research stating that sustainable 
behavioral change is considered to take six to eight months.122 This suggests that the long 
duration of the intervention is important for many women with CPP. 
 
Paper III 
The secondary analysis of possible associations between baseline characteristics and 
treatment outcome showed that long pain duration was a negative predictor, while higher 
baseline pain intensity was associated with more pain reduction. Only four baseline variables 
were included in the analyses, thus the results have limitations and can only be used for 
generation of hypothesis for future studies.  
 
The significant association between duration and treatment outcome has not previously been 
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shown in women with CPP,76, 123 but is supported by studies on other chronic pain conditions 
showing that lasting pain becomes more complex and the prognosis of recovery becomes 
poorer.40, 124 In a prospective study by Allaire et al. the variable “re-referral“ was identified as 
a predictor of poorer outcome. This may indirectly indicate failure of previous treatment 
efforts or prolonged pain, both leading to re-referrals, and thus support the importance of 
early and effective treatments. The finding of long pain duration as a negative predictor for 
pain reduction emphasize that early intervention is important.32, 40 
 
Our finding of higher baseline pain as associated with larger pain reduction during treatment 
contrasts with the results of two previous studies on CPP, where the opposite association was 
found.32, 76 The literature on other chronic pain conditions is conflicting regarding the 
direction of the association between baseline pain intensity and treatment outcome.125 This 
can have several explanations, such as different study populations, treatments and outcome 
measures.126 Additionally, the experience of pain is highly subjective and influenced by 
multiple factors, including sensory, emotional, cognitive and social dimensions.127 The 
association between high baseline pain and larger pain reduction might also be explained by 
the methodological effect of regression to the mean. Due to normal fluctuations participants 
with high baseline pain may report lower pain intensity at posttest.81, 125  
 
The presence of pain at multiple sites has received increasing attention in pain research, and 
the phenomenon has been described both as a predictor of pain outcome, and as a result of 
chronic pain.128, 82, 76  In CPP, a greater number of pain sites has been shown to be associated 
with more negative outcomes, such as anxiety, depression and worse quality of life.80, 128 In 
this study five women had worse pain in other areas of the body than in the pelvis. None of 
these women reported reduced pain after the intervention period, which may indicate that they 
were in need of some other type of intervention prior to receiving treatment focused on CPP. 
Due to the small group of women these observations are highly unsure. 
 
We did not detect the expected associations between anxiety and depression and treatment 
outcome.32, 126, 129, 40 One possible explanation of this is that the participants in our study 
reported mild or moderate scores for anxiety and depression, which was also the case in two 
former studies on CPP that also did not show such associations.76, 123 In a large population 
based study Ayorinde et al. (2017) identified two distinct clusters among their sample of 
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women with CPP, characterized by the absence or presence of psychosocial distress.38 It has 
been suggested that associations between patient characteristics and outcome predictors must 
be investigated in each individual patient, and may not be detectable at a group level.130 The 
role of psychological factors upon treatment outcome is definitely multifaceted and warrants 
further subgroup investigations. The women that dropped out of the trial showed some 
distinctly different characteristics, and these observations can serve as a reminder that patients 
with a more “vulnerable” profile need closer follow-up, and possibly different interventions.  
 
These secondary analyses were performed for the whole sample as one group, regardless 
which intervention they had received. Treatment group was included as a confounding 
variable, but the variables pain duration and baseline pain intensity came out as stronger 
predictors of change in pain intensity. The claim that physical therapy may provide valuable 
therapeutic effects for subgroups of women with CPP seem to be valid, whether it is delivered 
in primary care or in a group in a specialist health care setting.  
 
Discussion of methodological aspects 
In this chapter the strengths and limitations of the different methodological aspects of the 
thesis will be discussed. All the three papers were based on the same sample of participants, 
outcome measures and study setting, and a common discussion of the methodological aspects 
in the thesis follows.  
 
Internal and external validity are central terms in clinical research. Internal validity concerns 
the degree to which the correct conclusions are drawn about what actually happened in the 
study. External validity, or generalizability, concerns the degree to which the results or 
conclusions can be applied to people and events outside the study.131 
 
Study design 
In Paper I, a cross-sectional design was applied, as it is appropriate for describing 
characteristics of a sample. A limitation of this design is that no causality can be established 
between the historical variables. This means that the observed health status of women with a 




In Paper II the RCT-design was applied, which is the gold standard for establishing causality 
between an applied treatment and outcome and for comparison of different interventions. The 
pragmatic RCT-design was chosen due to the real world clinical setting, complex study 
intervention and lack of standardization of comparator group. This design strengthens the 
external validity as it is considered to be both applicable and generalizable to real world 
clinical settings.86 A limitation of the pragmatic RCT design is that the heterogeneity of 
practitioners, participants and delivery of treatment can make comparison to other trials 
challenging.86 The conduction of a pilot study prior to the full scale RCT could have sorted 
out some of the practical challenges that were discovered during the study period.132 
 
The secondary analysis in Paper III emerged based on the results from the RCT, and the 
results are presented as hypothesis generating for further studies. In order to increase the 
strength of a predictor analysis, the study should be designed with this purpose from the start, 
meaning larger sample size and pre-planned hypothesis of associations between baseline 
characteristics and treatment outcome.133 
 
Study sample  
The study sample was a selected group of women referred to physical therapy after 
assessment by a medical specialist in a tertiary hospital, meaning that the results cannot be 
generalized to others than women with CPP who fulfill the same inclusion criteria as used in 
this study. Although wide, the inclusion criteria were clearly defined, which is a strength. A 
limitation to the generalizability of the results is that among the eligible women only 57 % 
gave consent to participate. Reasons for this were economic concerns, long travel distance 
and inability to stay away from home for 10 days. This means that the women that gave 
consent are an even more selected group than described in the inclusion criteria. 
The sample size that was needed to detect clinical meaningful differences in change of pain 
intensity was calculated based on a previous study, and the necessary number of participants 
were retained through the final analyses. The relatively small sample size allowed us to 
perform thorough interviews with each of the 62 women. The small sample size can be 
regarded a limitation, though, especially related to analyses and interpretation of changes in 
the multiple secondary outcomes and small subgroups detected. However, no previously 
conducted RCTs applying a multimodal intervention on women with CPP have included a 
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higher number of participants,13, 83 and despite great efforts it took 18 months to include the 
62 women. To be able to include a higher number of participants a multi-center study would 
be necessary, and hence more economic and personnel resource demanding. 
 
Although we conducted a pragmatic RCT and the comparator group was referred to the usual 
treatment in primary care, these women were offered closer follow-up than in a non-research-
setting as they were provided with information about recommended physical therapists, they 
could contact the nurse associated to the project if they had queries, and they got their 
deductibles refunded. This may have lead to better adherence to the primary care physical 
therapy than in a non-research setting. 
 
The 18% dropouts are a threat to the internal validity. Some of the dropouts seem difficult to 
prevent, as the women withdraw or stopped replying. Data on four of the women that ended 
up as missing at 12 months could possibly have been collected and included in the intention 
to treat analysis. One of these women received a botox injection after two weeks of physical 
therapy in primary care, and the other three did not want to continue in the intervention group 
after the first session due to “to much else going on” or because they did not experience the 
desired improvements.  
 
Blinding 
Except for during the baseline tests and the person that scored the videos of the movement 
test, we were unable to blind participants, therapists and assessors for group allocation. The 
main cause for this was the impossibility to conceal whether the participants were referred to 
a group-based intervention organized by the hospital or to primary care physical therapy. 
However, prior to randomization both the participants and the therapists were informed that it 
was unknown which treatment that was more effective. 
 
Of practical reasons, the baseline assessors contacted the research department for 
randomization after inclusion of a new participant. The same person administered the three 
and six-months data collections, and conducted the 12-months tests. This complicated the 
concealment of treatment group allocation throughout the study. Involving another person had 




Outcome measures and data collection 
The primary objective of the RCT was to register changes in the women’s pain intensity from 
baseline to post-intervention at 12 months. The choice of primary outcome was based on 
several factors. First, pain intensity is a core aspect of the condition CPP. Secondly, the study 
intervention aimed to reduce pain in addition to improve daily function. Third, mean pain 
intensity is a commonly applied primary outcome measure and application of this ensures 
comparability with previous studies. The NRS is a recommended and frequently applied tool 
in clinical trials on chronic pain conditions.134 
 
As pain intensity in most cases varies both during the day and from day to day, we chose to 
record the mean pain during the last seven days. This also allowed direct comparison with the 
results of the previous RCT by Haugstad et al.13 To ensure registrations from all participants, 
the questionnaires were filled out when the women attended the outpatient clinic for testing. 
However, when retrospective questions are applied there is a risk of recall bias. Alternatives 
could have been to shorten the time period for registrations to for example four days, or to 
apply the more time consuming variant of daily registrations for a week and then calculate the 
average score. Using a smart phone with real time registrations could have been a good 
solution, and can be considered in future trials.  
 
CPP is a complex experience, and pain intensity is one among many dimensions.134 
According to the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT), selection of outcome measures should be based on “the domains of interest for 
the participants, the characteristics of the treatment and its putative effects”.134 With a 
complex condition and an intervention aiming to improve both pain and function, an outcome 
measure that embrace more dimensions of the condition could have been an alternative.135 
One example of such a measure is the “Patient Global Impression of Change scale”, which is 
described as suited for detecting clinically relevant changes in overall health status in chronic 
pain patients.136, 137 
 
A number of secondary outcome measures were applied in this study. In Paper I this allowed 
reporting of several aspects of the women’s situations. In retrospect, the number of secondary 
outcomes was too extensive in Papers II and III. The sample size calculation was not based on 
the secondary outcomes, thus these results must be interpreted with caution. A strength is that 
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all of the secondary outcome measures were validated, except from the scheme that recorded 
sexual function. Self-reported questionnaires were applied for all outcome measures except 
the Standardized Mensendieck test. A limitation of self-reported questionnaires is that they 
always involve a risk that respondents either underestimate or overestimate their symptoms. 
Several of the outcome measures were dichotomized, which gives a more imprecise estimate 
of the measures reported. This is particularly obvious in Paper III, where the duration variable 
was dichotomized at under or above six years – a rather rough measure. With a larger sample, 
the possibility to split in more categories could have given a more precise report of the 
association between duration and treatment outcome.  
The Standardized Mensendieck Test is validated for application on the patient group that are 
studied in this thesis. However, only one reliability-study has been performed and the 
application of the test is rather limited.88 Thus, further studies to ensure the reliability of the 
test is warranted. 
In our study, we did not include any manual testing of muscle quality, strength, flexibility, or 
other specific tests. The importance of the pelvic floor muscles is advocated in numerous 
reports on CPP, and myofascial pain and trigger points are likely to be present.138 However, 
as a holistic approach was emphasized here, the local pathology was not considered the main 
focus. Also, the fact that we did not record physical activity can be considered a limitation. In 
many chronic pain conditions, physical activity is limited due to pain and a response to 
decreased pain may be increased activity and improved functioning.139 The EQ5D-5L 
questionnaire includes questions about daily functions, and thus covers part of this aspect. 
Additionally, as stated above, the number of secondary outcomes was high. In this study it 
was necessary to limit the total number of outcome measures both considering how much you 
can demand from the participants, and to obtain the power of the study. 
 
The lack of active engagement of women with CPP in the planning and conduction of the 
study is a weakness. This could have brought other perspectives, provided important tips 




Study intervention and comparator group 
The study intervention was based on clinical guidelines and developed by experienced 
clinicians. This multimodal intervention was as standardized as feasible. However, the 
multifaceted nature of the intervention make it difficult to evaluate the effectiveness of each 
of its components.86 The EAU-guidelines does not specify how the exact organization, 
contents, or necessary contributions from multiple disciplines should be. In our study three 
different disciplines were involved, but the physical therapists made the main contributions. It 
is not known what is best in terms of involving multiple health professionals with specialized 
but narrow competence, or involving fewer disciplines with broader competence. The 
question of what is optimal versus what is sufficient is also relevant. An intervention that 
involves fewer disciplines, as the study intervention in this thesis, is less resource demanding 
both regarding organization and economy. 
 
Both the study intervention and the comparator were carried out in the ordinary clinical 
settings, which strengthens the external validity. The study intervention was designed with a 
specific combination of practitioners and in a certain setting, making the effect unsure when 
adapted by other therapists in different settings. 
 
The lack of standardization of the comparator group can be considered a limitation because of 
the heterogeneous treatment. In the pragmatic RCT the aim was to compare the study 
intervention with the physical therapy usually offered to women wit CPP in North-Norway. 
The concern of the unstandardized comparator group was thoroughly discussed in our 
research group when planning the study. As there is no consensus on a standardized physical 
therapy approach in CPP,12 comparing the intervention to treatment different from what is 
usually offered could be criticized as well. It would probably be challenging to make the 
primary care physical therapists provide a pre-designed treatment, as the knowledge of 
evidence based pain treatment; focus on individualization and patient involvement is among 
the therapist. Another solution could have been a multiple-arm design similar to that applied 
in the RCT by Ariza-Mateos et al. (2019),83 where the comparator groups received single 
modality treatment in the same setting as the intervention group. However, such a design 
would require more resources and a larger sample size. Finally, a wait-list comparator was 






Statistical validity refers to the extent to which the statistical analyses are appropriate. In 
Paper II the Students T-test for independent samples was applied to compare changes between 
pre- and post-treatment scores, and linear regression performed as sensitivity analyses to 
adjust for baseline values. These are appropriate analyses, although it is claimed that reporting 
group differences as actual scores at 12 months including baseline values as covariates are the 
analysis of choice.142 This method is termed analysis of covariance, often referred to as 
ANCOVA, and is known to produce unbiased estimates of treatment effect in the presence of 
baseline imbalance when groups are randomized. In our data material the results turned out 
the same either we applied the predetermined tests or ANCOVA, but for future studies the 
recommended analysis should be chosen.142 
 
The statistical power of the RCT was determined for the primary outcome, and it can 
therefore be expected that inadequate power may sometimes explain unexpected findings or 
lack of expected results for secondary outcome measures. 
 
Making a statistical analysis plan prior to data collection could possibly have avoided some of 








7 Conclusions  
The cross-sectional study showed that women with CPP are a heterogeneous group, with 
complex symptoms of both physical and psychological complaints. The heterogeneity 
indicates that there are several subgroups with different characteristics within the wide group. 
Women exposed to abuse have especially high scores related to analgesic use, sick leave, and 
they report more physical and psychological health complaints. Women with previous surgery 
report more analgesic use and sick leave, and lower pain intensity during intercourse, than 
those without previous surgery. 
 
The RCT showed a smaller than expected difference between the groups with respect to 
reduction in mean pelvic pain intensity after 12 months, but the difference was statistically 
significant. The intervention group showed additional improvements in the respiratory 
patterns and in pain-related fear of movements.  
 
Based on the secondary analysis we hypothesize that pain duration and pain severity is of 
distinct importance in terms of treatment outcome. The results in all the three papers 
strengthen the suggestions of existence of subgroups within the wide condition CPP, and 
there is a need for further tailoring of interventions.  
 
The conduction of this study provided valuable experiences regarding performing a RCT with 
a complex intervention and a heterogeneous group of participants, which will be helpful in 








8 Clinical implications and future research 
Treatment of CPP is challenging, and there does not seem to be a “quick fix” for the 
condition. In a bio-psycho-social perspective multiple factors influence a treatment process, 
and contribute to the results.143 The complexity of the participant’s health history and -status 
shown in this thesis highlights the need for health professionals to have specialized 
knowledge of chronic pain mechanisms. In order to tailor interventions to the individual 
women’s needs, thorough baseline assessments, preferably in a multidisciplinary setting, 
should be performed.76 Specific issues related to the pelvic area distinguish these women 
from other chronic pain patients. Sexual function, incontinence and constipation should be 
paid attention. In addition, it is important to be aware of the high prevalence of abuse 
exposure. Although not shown in our data, psychiatric symptoms are known to be poor 
prognostic indicators for treatment success, and thus essential to take into account in the 
assessment and treatment of CPP.144-146  
The finding of long pain duration as associated with poorer treatment outcome emphasize that 
early interventions should be sought. Many participants reported pelvic surgeries or other 
treatments without satisfactory results prior to referral for physical therapy. In many cases, 
consideration for a non-invasive intervention such as physical therapy may be appropriate at 
an earlier stage.147 Increased knowledge about which women that are at risk of developing 
long lasting and more complex CPP-condition is needed, as well as knowledge of factors that 
may be predictive for treatment outcome. This information can be applied when making 
treatment plans. Also, evaluations during treatment can identify women with worsening of 
symptoms that may be in need of other types of management.  
 
Overall, we argue that the results in this thesis support the recommendation for taking a broad 
bio-psycho-social approach and that a multimodal intervention including physical therapy 
should be further developed.46 The physical therapy component adds the expertise about the 
movement system with the other pain mechanisms.22 A discussion of alternative forms for 
multimodal approaches would be interesting to include in future works, as it seem difficult to 
integrate multidisciplinary and multimodal assessment and management in all stages of the 
health care systems. Single discipline treatment with multimodal approach may then be a 
good alternative.148 An even more tangible strategy can be to focus on increased knowledge 
of CPP, and to inform general practitioners and others about where to access useful 




There is a need of studies investigating which components of a multimodal intervention that 
are more beneficial for different women with CPP, as well as studies to evaluate group-based 
versus individually tailored interventions. The challenges regarding the contents of a 
comparator group must also be solved as discussed earlier. The fact that a large proportion of 
the eligible women in this study did not agree to participate should be considered when 
planning future studies, as well as the observations of the women that dropped out. Another 
subject for future studies would be to perform another follow-up 12 months after the end of 
treatment. 
To provide the desired knowledge, studies with clear descriptions of the participants and of 
the treatments investigated, are needed. Due to the limited evidence base on multimodal 
treatment for women with CPP, and the complex nature of the study intervention, a 
prospective cohort study could have been considered prior to an RCT. Allaire et al. (2019) 
performed such a cohort study in a interdisciplinary clinical setting, and their model can be an 
example of how to gain more knowledge about patient characteristics, development of the 
condition over time, prognostic factors and outcome predictors.1, 76 It would also be useful to 
evaluate the quality and applicability of available evaluation tools for women with CPP.	
It has been suggested that combining the quantitative and qualitative outcome measures is 
particularly relevant in complex conditions, such as CPP. A mixed model design could have 
been considered here, in order to include information about the meaning the women ascribe to 
the pain, and how they experience the interventions given and the treatment process.28  
 
In the process of determining which treatment offers that should be continued and which 
should not, the cost-effectiveness of implementing a treatment should be evaluated in addition 
to the clinical effect. This can involve examining the effect on other healthcare use and 
societal costs. Additionally, a consideration of the practicability of scaling up the intervention 
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Abstract
Background and aims: Chronic pelvic pain (CPP) in women 
is a complex condition that can seriously impact health 
and quality of life. Clinical guidelines for CPP place great 
demands on healthcare professionals, as they require both 
specialized knowledge about the pelvic area and knowl-
edge of the mechanisms of chronic pain. To ensure best 
possible assessment and treatment of these women it is 
important to bring about more knowledge of the special 
CPP features. The purpose of this paper is to describe the 
characteristics of women with CPP evaluated at the Univer-
sity Hospital of North Norway, and further referred to phys-
iotherapy. The frequency of having a history of abuse or 
previous pelvic surgery will also be reported, and analyses 
performed to investigate if subjective health status differs 
between women with and without these experiences.
Methods: We collected cross-sectional data from 
62 women with CPP aged 20–65 (mean age 38.0), referred 
to physiotherapy after assessment by medical special-
ists. Data were collected by semi-structured interviews 
for demographic variables and medical history, and self-
administered questionnaires on pain intensity, sexual 
function, urinary incontinence (UI), anal incontinence 
(AI), obstructed defecation syndrome (ODS), subjective 
health complaints (SHC) and symptoms of anxiety and 
depression.
Results: Pain duration of more than 10 years was reported 
by 42%, mean pain score was 4.7/10, and analgesics were 
used weekly by 48%. Previous pelvic or abdominal surgery 
was reported by 71%, and sick leave >12 weeks the last year 
by 34%. Reduced sexual desire was reported by 78%, dys-
pareunia by 73%, UI by 54%, AI by 23%, and obstructed def-
ecation syndrome (ODS) by 34%. More than 90% reported 
musculoskeletal or pseudoneurologic complaints. Anxiety 
and depression scores defined as requiring treatment were 
reported by 40%. Abuse was reported by 50%, and asso-
ciated with significantly more reports of ODS (p = 0.02), 
more SHC (p = 0.02) and higher anxiety scores (p = 0.009). 
Analgesic use and sick leave were significantly higher 
both among women with a history of abuse (p = 0.04 and 
p = 0.005) and among those with previous surgery (p = 0.04 
and p = 0.02). Women with previous surgery reported sig-
nificantly lower pain intensity during intercourse than 
those without previous surgery (p = 0.008).
Conclusions: Women with CPP have complex symptoms 
and high scores for both physical and psychological com-
plaints. Women exposed to abuse have especially high 
scores related to analgesic use, sick leave, ODS, anxiety 
and SHC. Women with previous surgery report more anal-
gesic use and sick leave, and lower pain intensity during 
intercourse, than those without previous surgery.
Implications: This study illustrates the complexity of CPP 
and highlights the need for health professionals to have 
specialized knowledge of the possible features of the con-
dition. Previous abuse seems to be more associated with 
poor scores on several health outcomes than surgery, but 
this needs to be investigated further.
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subjective health outcomes.
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1   Introduction
Chronic pelvic pain (CPP) is a common and debilitat-
ing condition, and population-based studies suggest a 
prevalence of 11–25% in Western European women [1, 2]. 
The European Association of Urology has defined CPP as 
“chronic or persistent pain perceived in structures related 
to the pelvis that has been continuous or recurrent for at 
least 6 months”. They additionally describe CPP as “often 
associated with negative cognitive, behavioral, sexual, 
and emotional consequences, as well as with symptoms 
suggestive of lower urinary tract, sexual, bowel, pelvic 
floor, or gynecological dysfunction” [3].
This rather broad definition reflects the complexity of 
CPP. Relative to the general female population both physical 
and psychological health scores are poorer in this group [2, 
4]. Repeated surgical procedures in the pelvic area, co-exist-
ing conditions, and traumatic experiences such as physical, 
sexual, or psychological abuse are suggested as possible 
risk factors for CPP [4]. Multiple referrals, investigations and 
treatments in different medical specialties are common [2], 
but in many cases no physical cause of the pain is identi-
fied or new interventions not possible, leaving a significant 
number of women with long-term pain [2, 5]. Concerning the 
correct extent of the condition it is also important to mention 
that it is recognized that many women with CPP do not seek 
help or are not referred to secondary care [2].
Clinical guidelines for CPP recommend that early 
assessment should involve investigations aimed at specific 
disease-associated pelvic pain and assessment of func-
tional, emotional, behavioral, sexual and other quality 
of life issues. They further recommend a multi-specialty 
and multi-disciplinary management with consideration of 
all symptoms [3, 6]. These recommendations place great 
demands on healthcare professionals, requiring both spe-
cialized knowledge about the pelvic area and peripheral 
pain mechanisms, and knowledge of prolonged pain and 
central pain mechanisms.
Women with CPP might be referred to a pain center with 
assessment and treatment within the scope of a biopsy-
chological perspective, however without focus on specific 
challenges in the pelvic region. On the other hand they can 
also be referred to different specialists such as gynecolo-
gists, urologists or colorectal surgeons that not necessarily 
have specialized skills in chronic pain management. After 
medical assessment many of these women are referred to a 
physiotherapist, a profession also with varying knowledge 
of CPP. Thus, it is important to bring about more knowledge 
of the special CPP features to enable early recognition of the 
condition and to ensure precise assessment and treatment.
The purpose of this paper is to describe the charac-
teristics of women with CPP evaluated at the University 
Hospital of North Norway, and further referred to physi-
otherapy. We also want to investigate if suggested risk 
factors such as history of abuse and previous surgical 
operations in the pelvic area are frequently reported, and 
if women with and without these experiences report dif-
ferent subjective health status.
2   Materials and methods
This study was based on cross-sectional data of 62 women 
who participated in a randomized controlled trial com-
paring two different physiotherapy treatments. The trial 
was conducted at the Norwegian National Advisory Unit 
on Incontinence and Pelvic Floor Health, University Hos-
pital of North Norway. All data was collected at the time of 
inclusion at the hospital’s Physiotherapy Outpatient Clinic 
by two trained physiotherapists, between March 2015 and 
November 2016. The data presented in this paper was col-
lected before randomization and start of treatment.
Participants were women referred to physiotherapy 
treatment following CPP diagnosis by a gynecologist, 
urologist, and/or colorectal surgeon. Women with pain 
defined as gynecologic, urologic, or gastroenterological 
and/or pain in the pelvic floor muscles for a minimum of 
6  months, aged 20–65  years, motivated to participate in 
the randomized trial, and able to speak and understand 
a Scandinavian language were included. If malignancy or 
conditions requiring special medical attention were dis-
covered the women were referred to relevant follow-up, 
and not considered for study participation.
The exclusion criteria were pregnancy, childbirth 
during the last year, drug addiction, serious psychiatric 
diagnosis, and previous treatment by the physiothera-
pists at the intervention program. Women with intraab-
dominal or pelvic surgery within the previous 6  months 
or Botolinum toxin injections in the pelvic area in the last 
4 months were also not eligible.
Demographic data and data on health-related history 
were obtained during a semi-structured interview. This 
included information about duration of CPP, use of anal-
gesics, previous treatment, other diagnosis, sick leave 
and previous abuse exposure (physical, psychological, 
or sexual). Questions on abuse exposure were asked at 
the end of the semi-structured interview, with the same 
phrasing for all women. For detailed information about 
the content of the interview see Appendix 1.
Pelvic pain intensity was assessed using a Numerical 
Rating Scale (NRS), an 11 point box scale in which zero 
represents no pain and 10 represents pain as bad as it 
could be [7]. The women were asked to rate their mean 
pain intensity during the last 7 days, and to state if pain in 
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the last week was worse, better, or unchanged compared 
to the previous month. The NRS has shown good sensitiv-
ity and validity [7, 8].
For information about sexual function a modified 
self-reported questionnaire originally developed by Træen 
et al. was used [9]. The questionnaire comprised four ques-
tions. First the women were asked whether they were sexu-
ally active, with answers reported as “yes” or “no”. If they 
answered affirmatively they were asked if they had expe-
rienced lack of sexual desire or dyspareunia over the past 
12 months. Answers were reported as “Yes” (“all the time”, 
“almost all the time”, and “quite often”) or “No” (“quite 
rarely” or “never”). In the last point the women were asked 
to register the intensity of dyspareunia on a NRS.
The subjective health complaints (SHC) questionnaire 
was used to register common somatic and psychological 
health complaints during the last 30 days [10]. The 29-item 
list consists of complaints in the categories musculoskel-
etal pain, pseudoneurology, gastrointestinal problems, 
allergy, and flu. The respondents provided a score for 
each of the complaints on a Likert scale ranging from 0 to 
3. We calculated the proportion of women who reported
complaints within each category and the number of single 
items, classified as absent (score 0) or present (score 1–3),
and we also calculated the proportion of “severe com-
plaints” (score 3) [10]. The SHC questionnaire is known to
be a reliable measure of SHC [10].
Common symptoms of anxiety and depression were 
measured using Hopkins Symptom Checklist (HSCL-25) [11]. 
The respondents indicated the extent to which they had 
experienced any of 25 different symptoms of anxiety and 
depression over the last 14  days using a four-point Likert 
scale ranging from 1 to 4. Separate mean scores for anxiety 
and depression items were calculated. A cut off point of 
1.75 was used to distinguish women with and without psy-
chiatric symptoms, and the dichotomized data are pre-
sented in the results section [11]. The HSCL-25 is known to 
be a reliable measure among Norwegian women, and its 
validity has been shown in a Swedish population [11, 12].
Urinary incontinence (UI) was defined as “the com-
plaint of involuntary leakage of urine” and documented 
by the self-administered questionnaire ICIQ-UI SF [13]. 
Scores range from 0 to 21, and in this study we used the 
dichotomized values to indicate no UI (score = 0) or UI 
(score ≥ 1) [14]. The questionnaire is validated [13] and the 
Norwegian version is found adequate for use after linguis-
tic validation [15, 16].
Information about anal incontinence (AI), defined as 
involuntary passage of fecal material and/or flatus [17], 
was collected using the validated St Marks interview score 
[18]. The score gives information about type and frequency 
of AI (gas, liquid, solid) and its impact on daily life, the 
need to wear a pad or plug, the use of constipating medica-
tion, and the lack of ability to defer defecation for 15 min 
[18]. Scores range from 0 to 24, and we used the dichoto-
mized scores so that 0–3 = “no AI” and 4–24 = “AI” [19, 20].
To record information about obstructed defecation 
symptoms (ODS) a five-item score developed and validated 
by Renzi et al. [21] was used. Each item is graded from 0 
to 5  with a maximum total score of 25, and the optimal 
cutoff point to discriminate between healthy participants 
and patients with ODS is found to be ≥9 [21]. We used the 
dichotomized values so that ≤8 = no ODS and ≥9 = ODS.
2.1  Statistical analyses
Descriptive statistics for continuous variables are presented 
with mean and standard deviation (SD) or median and 
interquartile range (IQR) as appropriate, and categorical 
variables are presented as percentages and frequencies (n).
To investigate differences in current subjective health 
status between women with and without a history of 
abuse and with and without pelvic surgery, the variables 
“sick leave ≥12 weeks last year”, “use of analgesics weekly 
in the last month”, “pelvic pain intensity”, “dyspareu-
nia”, “UI”, “AI”, “ODS”, “number of any SHC”, “number 
of severe SHC”, and “HSCL-25 score above 1.75” (included 
subscales for anxiety and depression) were tested sepa-
rately with bivariate tests. Independent samples t-tests or 
Mann-Whiney U-tests were used for continuous variables 
as appropriate, and the Pearson χ2-test for independence 
were used for categorical variables.
We used the total score for non-missing items when cal-
culating means for outcome measures with missing values. 
Outcome measures with more than 10% of missing items 
were not included in analyses. All tests were two-tailed and 
a p-value < 0.05 was considered statistically significant. Sta-
tistical analyses were conducted using SPSS version 25 [22].
3   Results
A total of 108 women were referred for study participation. 
Fifty percent (n = 62) of the referred women were included 
and gave consent, 29% (n = 31) declined to participate, and 
14% (n = 15) did not meet the inclusion criteria. Excluded 
participants were offered a referral to regular physiother-
apy treatment.
Characteristics of the included women are summa-
rized in Table 1. Current pain intensity was reported to be 
approximately the same as that experienced over the last 
4 weeks by 79% (n = 49), and 76% (n = 47) reported con-
stant pain during the last week. There was no significant 
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group difference in pain intensity among women report-
ing and not reporting analgesics use weekly the last 
month (mean pain 4.2/10 vs. 4.8/10, p > 0.05). The total 
number of surgeries among the 44  women (71%) who 
reported previous abdominal or pelvic surgery was 116 
(range 1–10) (Table 1).
Fifty percent (n = 31) of the women reported events 
perceived as abuse of a physical, psychological or sexual 
nature. Of these, 42% (n = 13) had been exposed to abuse 
as a child (≤16 years of age), 39% (n = 12) as an adult, and 
19% (n = 6) had been exposed to abuse both as a child and 
as an adult. We do not have complete information about 
type of abuse, as giving this information was optional.
Of the 62 women 79% (n = 49) reported being sexually 
active. Reasons for not being sexually active were dys-
pareunia (15%, n = 9) and no partner (6%, n = 4). Lack of or 
reduced sexual desire was reported by 78% (n = 38) of the 
sexually active women, and dyspareunia was reported by 
73% (n = 36). The median pain intensity during intercourse 
among the sexually active women was 5.5/10 (IQR = 4.5) on 
the NRS.
Ninety-eight percent (n = 61) of the women reported at 
least one musculoskeletal complaint on the SHC question-
naire. Pseudoneurological complaints, including sleep 
problems, tiredness, anxiety, depression, and sadness, 
were reported by 92% (n = 57). Information on the most 
Table 1: Characteristics of women with chronic pelvic pain, n = 62.
  Mean (SD) or percentage (n)
Age (years)   38.0 (12.4, range 20–65)
BMIa   26.6 (5.6)
Smoking   23% (14)
Cohabiting (with partner)   77% (48)
Children   1.6 (1.4)
Among parous women (n = 43)
 Children   2.4 (1.0)
 Vaginal delivery only   70% (30)
 Cesarean section only   12% (5)
 Both vaginal delivery and cesarean section   19% (8)
Higher educationb   45% (28)
Working or student (not receiving social benefits)   61% (38)
Currently on sick leave   32% (12)
Sick leave >12 weeks last year   47% (18)
Duration of pelvic pain
 1–4 years   31% (19)
 4–10 years   27% (17)
  > 10 years   42% (26)
Mean pelvic pain intensity last 7 days (NRSc 0–10)   4.7 (2.4)
Use of analgesics weekly in the last month   48% (30)
Urinary incontinence (ICIQ-UI-SF)   54% (n = 33)
Anal incontinence (St. Marks interview score ≥4)   23% (n = 14)
Obstructed defecation (ODS-score ≥9)   34% (n = 21)
Previous diagnosis in the abdomen/pelvic area   79% (48)
 – Ovarian cysts    – 35% (22)
 – Urinary tract infections, repeated    – 26% (16)
 – Endometriosis    – 15% (9)
Previous abdominal or pelvic surgery   71% (44)
Intraabdominal surgery
 – Gastrointestinal intraabdominal (excl. C-section)    – 34% (21)
 – Cesarean section (≥1)    – 21% (13)
 – Hysterectomy    – 15% (9)
 – Ovarian resection/extirpation    – 6% (4)
Vaginal or anal surgery
 Repair of OASISd among women with vaginal deliveries (n = 38)   21% (8)
 Hemorrhoidectomy or ligation   6% (4)
Tried non-surgical treatment prior to current referral   55% (n = 35)
aBMI = body mass index. bCompleted ≥1 year of University College or University. cNRS = numeric rating scale. dOASIS = obstetric anal 
sphincter injuries grade 3 or 4.
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reported complaints is presented in Fig. 1, including both 
the proportion reporting any complaints and propor-
tion reporting severe complaints. The most commonly 
reported complaints in the “other complaints” category 
were leg pain, gas discomfort, shoulder pain, upper back 
pain and sadness/depression.
Forty-five percent (n = 24) of the women scored above 
the cut off point for psychiatric symptoms on the HSCL-25, 
with a total mean score of 1.83 (SD = 0.5, n = 53) (data from 
nine  women missing, five did not receive the question-
naire at baseline and four did not fill inn sufficient number 
of items to be included in the analyses). Forty-six percent 
(n = 25) scored above the cut off point for symptoms of 
depression, with a mean score of 1.88 (SD = 0.5, n = 53), 
and 36% (n = 19) scored above the cut off point for anxiety, 
with a mean score of 1.76 (SD = 0.5, n = 53).
Table 2 shows the results of bivariate tests for differ-
ences in subjective health status among women exposed 
and not exposed to abuse. The same variables were 
tested for women with previous pelvic or intra-abdominal 
surgery, and the results are presented in Table 3.
4   Discussion
Our results show high rates of sick leave, sexual com-
plaints, musculoskeletal SHC, UI, AI, constipation and 
abuse exposure compared to previous reports of women 
with CPP [23, 24]. CPP characteristics including long dura-
tion of pain, previous pelvic or abdominal surgery, psy-
chiatric symptoms, and a large number of co-existing 
conditions or complaints were also confirmed in this 
study [2, 4]. Women exposed to abuse reported higher use 
of analgesics, more sick leave, more SHC, higher anxiety 
scores and ODS than women not exposed to abuse. 
Women reporting previous surgery used more analgesics, 
and they reported more sick leave and less dyspareunia 
than those not reporting surgery.
The relatively small sample size of this study is a limi-
tation. However, the low number of participants allowed 
us to perform thorough interviews with all of the women, 
which we believe provided more in-depth information. 
The included women represent a selected group, and 






















Fig. 1: The most reported subjective health complaints among women 
with chronic pelvic pain, n = 62. The red bar indicates the proportion of 
the sample reporting any complaints at all; the blue bar represents the 
proportion of the total sample reporting severe complaints.
Table 2: Subjective health status of women reporting abuse exposure versus not reporting abuse exposure, n = 62.
  Percentage (n), mean (SD) or median (IQR)
Exposed to 
abuse (n = 31)
  Not exposed to 
abuse (n = 31)
  Between group 
difference (p-value)
Mean pelvic pain intensity, last 7 days (NRSa 0–10) (n = 62)   5.0 (SD 2.6)   3.9 (SD 2.02)   0.063f
Use of analgesics weekly in the last month (n = 62)   61% (19)   35% (11)   0.04d,g
Sick leave more than 12 weeks in the last year (of those working, n = 38)   56% (9)   14% (3)   0.005g,e
Dyspareunia (NRSa 0–10) (among those sexually active, n = 49)   5.5 (IQR 4.3)   5.5 (IQR 5.3)   0.61h
Number of SHCb (any) (n = 62)   14 (IQR 12)   11 (IQR 6)   0.02h,e
Number of SHCb (severe) (n = 62)   1.0 (IQR 3)   0.0 (IQR 1.0)   0.043h,d
Total score HSCL-25c ≥1.75 (n = 55)   62% (18)   31% (8)   0.003g,d
Anxiety subscale HSCL-25c ≥1.75 (n = 55)   56% (15)   21% (6)   0.009g,d
Depression subscale HSCL-25c ≥1.75 (n = 55)   59% (16)   36% (10)   0.08g
Urinary incontinence ICIQ-UI-SF, score >0 (n = 61)   63% (19)   45% (14)   0.15g
Anal incontinence (St. Marks interview score ≥4) (n = 61)   32% (10)   13% (4)   0.08g
Obstructed defecation (ODS-score ≥9) (n = 62)   48% (15)   19% (6)   0.02g,e
aNRS = numeric rating scale. bSHC = subjective health complaints. cHSCL-25 = Hopkins Symptom Check List 25. dp < 0.01. ep < 0.05. 
fIndependent samples t-test. gPearson χ2-test. hWilcoxon-Mann-Whitney test.
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with CPP who fulfill the same inclusion criteria as used 
in this study. Among the women that were referred after 
assessment by a specialist doctor, 31 refused to partici-
pate. Although not reported systematically, we are aware 
that economic reasons, long travel distance, the neces-
sity to stay away from home for 10 days, to much bothers 
and possibility of being randomized to a group treatment 
were reasons given by some of the women. This may have 
influenced the group characteristics. The cross-sectional 
design itself implies that data cannot be used to infer any 
temporal associations between exposure and outcome, 
and there may be recall bias [25]. All questionnaires used 
in this study were validated except the one related to 
sexual function, because we were unable to find an appro-
priate and not to time consuming sexual function ques-
tionnaire that was validated in Norway.
The mean pelvic pain intensity of 4.7/10 is classified as 
“moderate to severe” [24] and most of the women reported 
constant pain, yet only half had used analgesics weekly in 
the last month. This is in agreement with the use of analge-
sics reported in a Danish study on women with CPP [24], but 
lower than the 60% reported among women with chronic 
pain in a large Norwegian population [26]. There may be 
several reasons why the women in our study report less 
analgesic use than the general chronic pain patient popula-
tion, including the observation that CPP patients appear to 
report lower mean pain intensity [27, 28]. Different methods 
of measuring analgesic usage may also give different results.
Twenty percent of the women in our study reported 
that they were currently on sick leave, and one third of 
the working women reported a minimum of 12 weeks sick 
leave in the last year. The same result was documented in 
a CPP-study from New Zealand [29], and 35% of women 
in a previous Norwegian randomized controlled trial on 
women with CPP were on sick leave at the time of data 
collection [23]. This is considerably higher than found in 
general among Norwegian women [30], and suggests that 
CPP may be a significant factor in work absence.
Half of the women in our study reported that they had 
been exposed to abuse. A survey of more than 700 women 
diagnosed with CPP reported that 46% had been exposed 
to abuse, indicating the magnitude of this problem among 
women with CPP [31]. Information about the total number 
of Norwegian women with CPP reporting physical, psy-
chological or sexual abuse does not exist, but the numbers 
of sexual abuse alone has been reported to be 15–20% [23]. 
The overall abuse rate including violence, threats of vio-
lence, or sexual assault in the general female population 
in Norway has been estimated to be 36% [32]. Although 
it appears that the numbers reported among women in 
our study are higher than compared to the general female 
population, we cannot directly compare these numbers 
as different phrasing, definitions and data collection 
methods and periods have been used.
Sexual function is affected by pain during intercourse 
and reduced sexual desire [3], and the majority of the women 
in our study were sexually active despite these symptoms. 
Previous studies on women with dyspareunia have shown 
that reasons for this can be a prioritization of the part-
ner’s enjoyment before their own or expectations from the 
partner or the community [33], but this was not explored in 
our study. Desrochers et al. suggested that the psychosocial 
Table 3: Subjective health status of women with previous pelvic or intraabdominal surgery versus women not reporting surgery, n = 62.
 
 




  No previous 
surgery 
(n = 18)
  Between group 
difference 
(p-value)
Mean pelvic pain intensity, last 7 days (NRSa 0–10) (n = 62)   4.7 (2.1)   4.0 (3.0)   0.4f
Use of analgesics weekly, the last month (n = 62)   57% (25)   28% (5)   0.04g,e
Sick leave more than 12 weeks the last year (of those working, n = 39)  41% (16)   11% (2)   0.02g,e
Dyspareunia (NRS 0–10) (among those sexually active, n = 49)   4.5 (IQR 4.8)   7.5 (IQR 4.8)   0.008h,d
Number of SHCb (any) (n = 62)   11.5 (IQR 7.5)  13.5 (IQR 8.0)   0.2h
Number of SHCb (severe) (n = 62)   1.0 (IQR 1.75)  1.0 (IQR 2.25)   0.7h
Total score HSCL-25c ≥1.75 (n = 55)   47% (17)   41% (7)   0.7g
Anxiety subscale HSCL-25c ≥1.75 (n = 55)   33% (12)   41% (7)   0.6g
Depression subscale HSCL-25c ≥1.75 (n = 55)   44% (16)   47% (8)   0.9g
Urinary incontinence (ICIQ-UI-SF score >0) (n = 61)   56% (24)   50% (9)   0.7g
Anal incontinence (St. Marks interview score ≥4) (n = 61)   28% (12)   11% (2)   0.1g
Obstructed defecation (ODS-score ≥9) (n = 62)   34% (15)   33% (6)   0.9g
aNRS = numeric rating scale. bSHC = subjective health complaints. cHSCL-25 = Hopkins Symptom Check List 25. dp < 0.01. ep < 0.05. 
fIndependent samples t-test. gPearson χ2-test. hWilcoxon-Mann-Whitney test.
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burden of genital pain is heavier due to feelings of shame, 
inadequacy, and low self-esteem [34]. Our results emphasize 
that sexual function, dyspareunia and desire are important 
to address during assessment and treatment.
We found higher prevalence of UI, AI and ODS among 
the women in our study than are reported in studies of the 
general population [35–37]. These findings reflect some of 
the special characteristics of women with CPP, and illus-
trates how they differ from other chronic pain patients 
and need more specialized competence.
To our knowledge, there are no comparable data 
on the occurrence of SHC in women with CPP. We found 
considerably higher scores on all parameters of the SHC 
questionnaire in our sample than in the general female 
population in Norway. The highest reports were on low 
back and neck pain the last month, which was reported by 
about 80% of our sample compared to 45% in the general 
population [38]. In our study 78% of the women reported 
headache, compared to 58% in the general female popula-
tion [38]. This confirms that women with CPP have health 
concerns beyond the pelvic and abdominal area.
Abuse is identified as a potential risk factor for CPP [4], 
but only a few previous studies have provided information 
on the occurrence of abuse and associations with health 
status in women with CPP [31, 39, 40]. Women with a history 
of bullying or abuse have been shown to have poorer scores 
on both somatic and psychological health measures [39], 
and several reports indicate that exposure to abuse of any 
kind can lead to a higher risk of poor health later in life [31, 
40–42]. This is in agreement with our findings showing 
more symptoms of anxiety or depression and more SHCs 
among women exposed to abuse. We also found that those 
exposed to abuse had significantly more sick leave and 
used more analgesics, suggesting that abuse exposure may 
have significant impacts on both on the complexity and the 
severity of the CPP condition. Significantly higher numbers 
were shown for ODS among women who reported exposure 
to abuse, and although not statistically significant these 
women also had more complaints of UI and AI than women 
not exposed to abuse. We did not find a statistically signifi-
cant association between abuse and pain intensity, which 
is in line with the findings in As-Sanie et al. [40] although 
reported by others [4]. Women exposed to abuse did report 
higher mean pain intensity the last 7 days though.
We found that women with previous surgery had been 
more on sick leave and used significantly more analgesics 
than those without. Notably, they also reported lower pain 
intensity during intercourse than women without previous 
surgery. We have no explanation of this finding. In some 
cases, surgery may have alleviated pain originating from 
local pathologies and thereby also led to less dyspareunia. 
The women with previous surgery also had higher scores 
of UI, AI and ODS than those without surgery, although 
not statistically significant. In contrast to other reports, 
we did not find associations between having had a surgery 
and scores of anxiety, depression, or SHC [2, 4]. The lack 
of a control group without CPP may explain the absence 
of significant associations, and our study sample was too 
small to run subgroup analysis of those who had received 
different types of surgeries. Further studies investigating 
possible associations between number and types of sur-
geries and the different health outcomes are warranted.
5   Conclusions and implications
Our study contributes to the understanding of the com-
plexity seen in this group of women, and thus supports 
the recommendation for taking a broad biopsychoso-
cial and multidisciplinary approach [43]. However, this 
kind of approach may be more resource demanding and 
not always possible to implement, and single discipline 
treatment with multimodal approach may then be a good 
alternative [5]. Long duration of pain and high levels of 
psychiatric symptoms such as anxiety and depression 
are known to be poor prognostic indicators for treat-
ment success. It is essential for clinicians to take this into 
account in the assessment and treatment of CPP [3, 6, 44]. 
Specific issues related to the pelvic area, as sexual func-
tion/dysfunction, incontinence and constipation should 
also be paid attention. In addition, the high prevalence of 
abuse exposure is of great importance.
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Appendix
Appendix 1: Interview-guide for data on demographics and health-related history.
  Actual numbers/
answers recorded
  Pre-defined response categories
Age   X  
Year of birth   X  
Height   X  
Weight   X  
Do you smoke?     Yes/No
Civil status     Married or cohabiting
Living alone or with children
What is your highest level of completed education?     Completed <1 year, or
≥1 year of University College or University
What is your work status?     Answers were dichotomized into:  
 (1) Working or student
 (2)  Receiving social benefits (including 
unemployment)
Have you been on sick leave because of the pelvic pain the last 
3 years?
    Yes/No
 If yes approximately how many weeks the last year and the last 
3 years
  X  
Number of children   X  
When did your pelvic pain start?     6 months, 7–12 months, 1–2 years, 
2–4 years, 4–6 years, 6–10 years, more 
than 10 years ago
Have you ever had any surgery in the pelvic or abdominal area?     Yes/No
If yes,
  how long ago?
  how many surgeries in total?
  X  




Have you had other diagnosis/diseases related to the pelvic area 
than the pelvic pain?




Neurologic condition/injury,  














Have you used any pain medicines/analgesics because of your 
pelvic pain the last 4 weeks?
    Less than weekly
Every week but not daily
Daily
Not used
Have you been exposed to events that you experienced as 
abusive – either physical, psychological or sexual?
    Yes/No
If yes,
  when did the abuse happen?
  optional to add more information about the abuse?
   
Child (under 16)
Adult (16 or older)
aOASIS = obstetric anal sphincter injuries.
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Abstract
Introduction: Chronic pelvic pain in women is a complex condition, and physical 
therapy is recommended as part of a broader treatment approach. The objective of 
this study was to compare structured group-based multimodal physical therapy in a 
hospital setting (intervention group) with primary-care physical therapy (comparator 
group) for women with chronic pelvic pain.
Material and methods: Women aged 20-65 years with pelvic pain ≥6 months and re-
ferred for physical therapy were eligible. The primary outcome measure was change 
in the mean pelvic pain intensity from baseline to 12 months, measured using the 
numeric rating scale (0-10). Secondary outcomes were changes in scores of “worst” 
and “least” pain intensity, health-related quality of life, movement patterns, pain-
related fear of movements, anxiety and depression, subjective health complaints, 
sexual function, incontinence, and obstructed defecation. The differences between 
the groups regarding change in scores were analyzed using the independent t test and 
Mann-Whitney U test. Sensitivity analysis of the primary outcome was performed 
with a linear regression model adjusted for the baseline value. A P value <.05 was 
considered statistically significant.
Results: Of the 62 women included, 26 in the intervention group and 25 in the com-
parator group were available after 12 months for data collection and analysis. The 
difference between the groups for change in the mean pain intensity score was −1.2 
(95% CI −2.3 to −0.2; P = .027), favoring the intervention group. The intervention 
group showed greater improvements in respiratory patterns (mean difference 0.9; 
95% CI 0.2-1.6; P = .015) and pain-related fear of movements (mean difference 2.9; 
95% CI −5.5 to −0.3; P = .032), and no significant differences were observed between 
the groups for the other secondary outcomes.
Conclusions: Although the reduction in the mean pelvic pain intensity with group-
based multimodal physical therapy was significantly more than with primary-care 
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1  | INTRODUC TION
Chronic pelvic pain (CPP) in women is a complex condition, with 
a suggested worldwide prevalence of 6%-27%.1 CPP is defined 
as “chronic or persistent pain for at least 6 months, perceived 
in structures related to the pelvis, and often associated with 
negative cognitive, behavioral, sexual and emotional conse-
quences and symptoms of lower urinary tract, sexual, bowel, 
pelvic floor or gynecological dysfunction.”2 CPP is further sub-
divided into pain syndromes according to the location of the 
pain; however, in this study, we did not differentiate between 
these syndromes.2
Compared with the general female population, women with CPP 
report poorer total health, higher number of surgeries in the pel-
vic area, and more incidences of physical, sexual, and psychological 
abuse.1-3 Altered movement and respiratory patterns are observed,4 
and pain-related fear of movements are reportedly present.5 Long 
symptom duration and extensive investigations and treatments 
in different specialties are reported, often without satisfactory 
results.1
Clinical guidelines recommend a biopsychosocial approach in-
cluding physical therapy, pain education, and active patient partici-
pation.2 A systematic review of physical therapy treatment for CPP 
summarized that positive results can be achieved with single modal-
ities such as manual techniques and exercises, but the evidence is 
limited.6 Physical therapy focusing on body awareness and cognitive 
techniques has been highlighted as a promising therapy, and a future 
avenue for research in CPP.6
Group-based physical therapy is considered time saving and cost 
efficient; it can be as effective in reducing pain as individual treat-
ment and can provide social affinity for the participants.7 Despite 
this, no randomized controlled trials (RCTs) on group-based physical 
therapy for CPP have been identified.
A group-based multimodal physical therapy program that com-
bines body awareness therapy and patient education has been devel-
oped at the Pelvic Floor Center at the University Hospital of North 
Norway.8-10 Traditionally, women with CPP are referred for prima-
ry-care physical therapy after assessment by specialist doctors at 
hospitals.
The objective of this RCT was to compare group-based multi-
modal physical therapy (intervention group) with primary-care phys-
ical therapy (comparator group) in women with CPP. The primary 
hypothesis was that the intervention group will show greater re-
duction in the mean pain intensity than the comparator group after 
12 months.
2  | MATERIAL AND METHODS
This was a parallel group RCT with an allocation ratio of 1:1. 
Participants were recruited from the outpatient clinic at the Pelvic 
Floor Center at the University Hospital of North Norway, after as-
sessment by medical specialists. Eligibility and exclusion criteria are 
listed in Table 1.
The study intervention was based on the biopsychosocial model,11 
combined body awareness therapy,8,12 patient education,9,13 and 
cognitive approach of “acceptance and commitment therapy”10 in a 
group setting. There was a pre-planned schedule, with an initial 10-
day session followed by 2-day sessions after 3, 6, and 12 months. 
The aim was to reduce pain and improve daily function by challenging 
avoidance habits and providing new positive body experiences.8,12 
Detailed information about the intervention is shown in Supporting 
material, Table S1 (schedule) and Table S2 (TidiER checklist).
Women in the comparator group were referred to a physical 
therapist in primary health care with competence in women's 
health. The therapists received an information letter (Supporting 
material, Appendix S1), and they were asked to provide treatment 
according to their academic competence and in consultation with 
the woman. The deductibles of the physical therapy treatment 
were refunded.
The randomization database was administered by the Clinical 
Research Department at the hospital, and was available only for the 
primary researcher and the project leader. Randomization with alter-
nating block sizes of four and six was applied. A nurse at the Pelvic 
Floor Center provided the referrals to the treatment groups.
Baseline data were collected at the outpatient clinic at the time 
of inclusion before randomization, and all outcomes were collected 
again after 12 months. Information about pain intensities was also 
collected by mail at 3 and 6 months. Women who did not manage 
to travel to the hospital for the post-test for practical reasons were 
contacted by phone and mail. Two physical therapists (ASN and 
MFE) performed the baseline and follow-up tests.
Funding information
The Norwegian Fund for Post-Graduate 
Training in Physical Therapy and Northern 
Norway Regional Health Authority funded 
this study. The funding sources had no 
involvement in any stages of the study.
physical therapy, the difference in the change between the groups was less than ex-
pected and the clinical relevance is uncertain.
K E Y W O R D S
body awareness, chronic pelvic pain, group-based, patient education, physical therapy, 
randomized trial, women
Key Message
The reduction in the mean pain intensity with group-based 
multimodal physical therapy in a hospital setting was sig-
nificantly more than that with primary-care physical ther-
apy, but the difference in the change between the groups 
was less than expected and the clinical relevance is unclear.
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A semi-structured interview was used to collect demographic 
information (age, body mass index, smoking, children, civil status, 
education, and work status) and medical history (pain duration, pre-
vious surgeries, other diagnosis, and abuse exposure). At 12 months, 
the number of consultations and type of treatment were also regis-
tered. Supporting material, Appendices S2 and S3 show the inter-
view guides.
The primary outcome measure was change in mean pain inten-
sity from baseline to 12 months of follow up. The mean pelvic pain 
intensity during the previous 7 days was recorded on the validated 
11-point numeric rating scale (NRS, 0 = no pain, 10 = worst pain 
imaginable).14
The “worst” and “least” pain intensities during the last 7 days 
were registered as secondary outcome measures using the NRS.14
Movement patterns were assessed using the Standardized 
Mensendieck test, which evaluates performance of standing and 
sitting posture, active movements, gait, and respiration patterns ac-
cording to criteria based on functional anatomy.15 The test was video 
recorded before a blinded physical therapist scored the five domains 
on a scale of zero to seven (0 = least optimal, 7 = optimal) (Supporting 
material, Appendix S4). The Standardized Mensendieck test was val-
idated in a sample of Norwegian women with CPP.15
Pain-related fear of physical movement and activity was reg-
istered with the validated Tampa scale for Kinesiophobia.16 The 
women reported to what extent they agreed with the 13 different 
statements regarding associations between movement and possi-
ble injury or pain on a four-point Likert scale (1 = strongly disagree, 
4 = strongly agree), and the total was calculated in the score range 
of 13-52.
Health-related quality of life was measured using the EQ5D-5L 
questionnaire. An EQ5D-index and an EQ visual analogue scale 
(VAS) score were reported.17 The EQ5D-index ranges from −0.624 
to 1.000, with higher scores indicating better health, whereas the 
EQ VAS records total health on a VAS (0-100), where 100 is the best 
health you can imagine.17
Symptoms of anxiety and depression were recorded using 
the Hopkins Symptom checklist-25 (0-4, higher scores indicating 
more severe symptoms).18 Common somatic and psychological 
health complaints during the last 30 days were recorded using the 
Subjective Health Complaints questionnaire (0-87, higher scores in-
dicating more complaints).19 The presence and extent of urinary in-
continence (yes/no, scores 0-21),20 anal incontinence (yes/no, scores 
0-24),21 and obstructed defecation (yes/no, scores 0-25)22 were re-
corded using validated questionnaires. Sexual function was mapped 
with questions regarding whether the women were sexually active 
(yes/no), had reduced/lack of sexual desire (yes/no), and/or had 
presence of pain during intercourse (yes/no). Pain intensity during 
intercourse was registered using an NRS (score 0-10).23,24
2.1 | Statistical analyses
The sample size was calculated based on the results from an RCT 
conducted on women with CPP that applied an intervention similar 
to the one in this study, though it was individually delivered. The 
aforementioned study showed a change of 2.2 on the NRS for mean 
pain intensity between the groups after 3 months,25 which indicated 
a difference of one standard deviation in the change. Based on these 
assumptions, the effect size was estimated as “1”. With a significance 
level of 0.05, a power of 90%, and an estimated dropout rate of 30%, 
33 women should be included in each group.
Descriptive statistics were presented as mean and standard de-
viation or median and interquartile range for the continuous vari-
ables, and frequencies and percentages for the categorical variables. 
In case of missing data on sub-items of the secondary outcome mea-
sures, averages of the available responses were used.26
Statistical analyses followed the intention-to-treat approach. 
For continuous data, independent samples t test or Mann-Whitney 
U test was used for primary analyses of group differences in the 
change in the groups from baseline to 12 months. The assumptions 
for parametric tests of normal distribution of residuals and equal-
ity of variances were checked before analyzing the data. For the 
categorical variables, changes in the number of women reporting 
problems were described. Sensitivity analysis of the primary out-
come was performed with a linear regression model adjusted for the 
baseline value. The significance level was set at P = .05. Statistical 
analyses were conducted using the Statistical Package for the Social 
Sciences, version 25 for Macintosh (IBM SPSS Statistics).27
2.2 | Ethical approval
This study was conducted in accordance with the principles of the 
Declaration of Helsinki. Written and oral study information was 
provided to the participants, and the informed consent forms were 
signed. The study was approved by the Regional Committee for 
TA B L E  1   Eligibility criteria
Inclusion criteria Exclusion criteria
Norwegian-
speaking women
Malignancy and conditions requiring special 
medical attention
Age 20-65 years Pregnancy at the time of inclusion or 
childbirth during the previous 12 months




participate in a 
group intervention
Serious psychiatric diagnosis
Previous treatment by the physical 
therapists involved in the intervention
Intra-abdominal or pelvic surgery within the 
last 6 months
Botulinum toxin injections in the pelvic area 
in the last 4 months
aEngeler et al, European Association of Urology Guidelines on Chronic 
Pelvic Pain 2017. https://uroweb.org/guide line/chron ic-pelvi c-pain/. 
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Medical and Health Research Ethics North (18.09.2014 2014/1398) 
and by the Institutional Review Board at the University Hospital 
of North Norway (0444/24.02.2015). The trial was registered at 
clinicaltrials.gov (NCT02356796, 5 February 2015) and reported 
in accordance with the CONSORT statement (Supporting material, 
Table S3).28
2.3 | Deviations from registered trial protocol
Regrettably, the registration of the primary outcome at clinicaltrials.
gov was misleading, including mean, least, and worst recorded pain 
intensities at three different time-points. Some secondary outcomes 
were also registered as measured at different time-points. However, 
the objective of the trial was to analyze changes from baseline to 
12 months. Additionally, the sample size calculation was 46 and not 
50, as registered at clinicaltrials.gov.
3  | RESULTS
Sixty-two women were randomly assigned to the intervention group 
(n = 30) and the comparator group (n = 32) between March 2015 
and November 2016. Data collection was completed in January 
2017, with the data of 26 and 25 women available for the 12-month 
analyses from the intervention and comparator groups, respectively. 
Participant selection flow, including reasons for dropout, is shown 
in Figure 1. Table 2 provides the baseline characteristics of the 
participants in both groups. A detailed description of the sample was 
provided in a previously published paper.24
The majority of women in the intervention group attended all 
the sessions. One woman attended only for the first 10-day ses-
sion, and seven attended 12-14 days of the total 16 treatment days 
(median 16, interquartile range 2). In the comparator group the me-
dian number of physical therapy consultations was 14 (interquar-
tile range 29). One-third of the comparator group women reported 
that they had received pelvic floor muscle training combined with 
general exercises and/or relaxation exercises, 50% had received 
soft-tissue treatment alone or in combination with exercises, and 
50% reported that dialogue with the therapist was a part of the 
treatment.
For the primary outcome the group-difference in change was 
−1.2 (95% CI −2.3 to −0.2, P = .027) (Table 3). In the intervention 
group, 19 women reported improvement, whereas four women re-
ported no change and three reported worsening in mean pain inten-
sity as compared with the 17, 3, and 5 women, respectively, in the 
comparator group. Except for a lack of reduction in pain, no adverse 
effects were registered.
Regarding the secondary outcomes, statistically significant 
differences were detected only in the respiratory patterns and 
pain-related fear of movements (Tables 4 and 5). Sixteen women 
(62% and 64% in the intervention and comparator groups, respec-
tively) from both groups reported being sexually active both at 
baseline and 12 months. Among those, 12 (86%, two missing) in 
the intervention group and 12 (75%) in the comparator group re-
ported reduced sexual desire at baseline. After 12 months, eight 
F I G U R E  1   Participant flow including reasons for dropout
Assessed for eligibility
(n = 108)
Randomized (n = 62)
Allocated to the study intervention (n = 32)
Received allocated intervention (n = 28)
Did not receive allocated intervention (n = 4)
Excluded before inclusion
(n = 46)
- Not meeting inclusion 
criteria (n = 15)















Allocated to comparator treatment (n = 30)
Received allocated intervention (n = 29)
Did not receive allocated intervention (n = 1)
Analyzed at 12 months (n = 26)
Excluded from analysis (n =0)
Discontinued intervention (n = 3)
Lost to follow-up (n = 6)
Discontinued intervention (n=1) 
Lost to follow-up (n = 3)
Analyzed (n = 25)
Excluded from analysis due to missing 12-
months data (n = 2)
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Intervention group (n = 32)
Comparator group 
(n = 30)
Mean, n or 
median
SD, % or 
IQR




Age, years 39.7 10.9 36.2 13.8
BMI, kg/m2 26.7 5.8 26.9 5.6
Smoking, yes 8 25 6 20
Premenopausal, yes 23 77 22 76
Children, number 2.0 1.5 1.3 1.2
Married or cohabiting, yes 27 84 21 70
Education, highera , yes 13 41 15 50
Working or student, yes 16 50 18 60
Currently on sick leave, yes 5 16 7 23
Sick leave >12 weeks last 
year, yes
11 34 7 23
Receiving social benefits, yes 12 38 11 37
Previous surgery (lower 
abdomen or pelvis), yes
22 71 20 67
Previous surgeries, number 1.5 0-3 1.0 0-2
Previous diagnosis in the pelvic area, yes
Ovarian cysts 13 41 9 30
Urinary tract infections, 
repeated
9 28 7 23
OASIS 4 13 4 13
Endometriosis 3 9 6 20
Exposed to abuse (physical, 
psychological or sexual), yes
13 41 18 60
Duration of pelvic pain, years
1-2 4 12.5 4 13.3
2-4 7 21.9 4 13.3
4-6 8 25 4 13.3
6-10 1 3.1 4 13.3
>10 12 37.5 14 46.7
Mean pelvic pain intensity, 
NRS
4.4 2.0 4.5 2.8
Abbreviations: BMI, body mass index; IQR, interquartile range; NRS, numeric rating scale; OASIS, 
obstetric anal sphincter injuries; SD, standard deviation.
aCompleted ≥1 year at the University College or University. 
TA B L E  2   Baseline characteristics of 
the participants in the intervention group 
and comparator group





Change baseline to 
12 months
Difference in change between the groups
Primary analysis Sensitivity analysisa 
Mean SD Mean SD Mean 95% CI Mean 95% CI P Mean 95% CI P
Intervention 
group (n = 26)
4.7 2.0 3.0 2.4 −1.8 −2.6 to −1.0 −1.2 −2.3 to −0.2 .027 −1.2 −2.3 to −0.1 .030
Comparator 
group (n = 25)
4.5 2.8 4.0 2.9 −0.5 −1.3 to 0.3
Abbreviations: NRS, numeric rating scale; SD, standard deviation.
aAdjusted for baseline values of mean pain intensity. 
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(50%) in the intervention group and 10 (63%) in the comparator 
reported reduced sexual desire. At baseline, nine (75%, four miss-
ing) in the intervention group and 11 (73%, one missing) in the 
comparator group reported painful intercourse. After 12 months, 
six (38%) women in the intervention group and 10 (63%) in the 
comparator group reported painful intercourse. Pain intensity 
during intercourse was reduced by 3.0 on the NRS from baseline 
to 12 months in the intervention group compared with a reduc-
tion of 1.1 reduction in the comparator group (difference in groups 
−1.9; 95% CI −5.6 to 2.0; P = .326). There were no differences in 
the total scores for incontinence or obstructed defecation be-
tween the groups (Table 5).
4  | DISCUSSION
To our knowledge, this is the first RCT comparing a group-based 
treatment consisting of body awareness therapy, patient educa-
tion, and cognitive techniques with primary-care physical therapy 
for women with CPP. We found a smaller than expected difference 
between the groups with respect to reduction in mean pelvic pain 
intensity after 12 months, but the difference was statistically sig-
nificant. The intervention group showed additional improvements 
in the respiratory patterns and in pain-related fear of movements. 
However, changes in “worst” and “least” pain intensities, health-
related quality of life, other movement patterns, symptoms of anxi-
ety and depression, subjective health complaints, sexual function, 
incontinence, and obstructed defecation were not statistically dif-
ferent between the groups.
The strengths of this study are the RCT design, validated out-
come measures, and the use of a definition and intervention in 
accordance with the clinical guidelines.2 The primary outcome 
measure was defined as change in pain intensity, which reflects just 
one aspect of CPP,1 and other end points might be better suited to 
this type of intervention. Comparing the study intervention with 
non-standardized physical therapy can be considered a limitation 
because of the heterogeneous treatment. However, there is no 
consensus on a standardized physical therapy approach in CPP,6 
and comparing the intervention with the “usual treatment” offered 
to these women provides real-world clinical data. Furthermore, 
the lack of blinding of the data collectors and patients is a limita-
tion, and there might be a selection bias because one-third of the 
eligible women declined to participate. Reasons for not attending 
were economic concerns, and practical or emotional challenges of 
staying away from home. The dropout rate was 18%, which in-
fluences the generalizability of our findings. These results apply 
only to women with characteristics similar to the 51 participants 
included in the 12-month analyses of this study. The limited num-
ber of participants and the low power of the study mean that the 
results of all the secondary outcomes should be interpreted with 
caution.
The difference between the groups regarding the change in 
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TA B L E  5   Differences between the intervention (n = 26) and comparator (n = 25) groups regarding the changes in the secondary 


















IQR Mean 95% CI P
Worst pain, NRS 0-10
Intervention group n = 24 6.8 2.4 4.0 3.3 −2.7 3.5 −1.4 −0.4 to 3.1 .117
Comparator group, n = 25 6.3 2.6 5.0 3.1 −1.3 2.5
Least pain, NRS 0-10
Intervention group n = 21 2.2 2.0 1.7 2.0 −1.7 2.1 0.3 −0.9 to 1.4 .651
Comparator group n = 22 2.2 2.5 1.5 1.6 0.5 1.4
Movement patterns, SMT 0-7
Posture
Intervention group n = 24 4.8 0.7 5.0 0.5 0.2 0.7 0.3 −0.1 to 0.7 .104
Comparator group, n = 22 4.8 0.6 4.8 0.7 −0.1 0.7
Active movements
Intervention group n = 24 4.2 1.2 5.0 0.7 0.7 1.1 0.1 −0.5 to 0.8 0.637
Comparator group, n = 22 4.0 1.1 4.7 1.0 0.6 0.9
Sitting posture
Intervention group n = 23 5.1 1.3 5.5 1.1 0.4 1.0 0.1 −0.7 to 0.6 .838
Comparator group, n = 22 4.9 1.2 5.2 1.0 0.3 1.2
Gait
Intervention group n = 22 4.5 1.2 5.1 1.0 0.5 0.8 0.0 −0.6 to 0.6 .881
Comparator group, n = 22 4.2 1.3 4.7 1.4 0.5 1.1
Respiration
Intervention group n = 23 4.1 1.3 5.0 1.2 0.8 1.4 0.9 0.2-1.6 .015
Comparator group, n = 21 3.9 1.2 4.1 1.0 −0.1 0.9
Pain-related fear of movements, TSK 13-52
Intervention group, n = 24 24.4 4.8 19.4 4.3 −5.0 3.7 −2.9 −5.5 to −0.3 .032
Comparator group, n = 25 23.0 6.3 20.8 5.9 −2.1 5.3
Health-related quality of life, EQ5D-5L
EQ5D index value, −0.624 to 1.000
Intervention group, n = 26 0.67 0.14 0.72 0.19 0.05 0.16 −0.01 −0.09 to 
0.07
.814
Comparator group, n = 25 0.64 0.19 0.70 0.21 0.06 0.13
EQ-VAS, 0-100
Intervention group, n = 24 58.0 19.1 62.1 20.3 4.1 22.4 −2.0 −14.9 to 
10.9
.757
Comparator group, n = 25 58.2 22.5 64.2 18.1 6.1 22.5
Symptoms of anxiety and depression, HSCL-25 0-4
Intervention group, n = 21 1.83 0.45 1.52 0.38 −0.30 0.46 −0.15 −0.41 to 
0.11
.241
Comparator group, n = 22 1.78 0.51 1.64 0.54 −0.15 0.39
Subjective Health Complaints, SHC 0-87
Intervention group, n = 22 20.9 11.6 22.4 12.2 1.5 16.8 7.2 −2.6 to 17.1 .146
Comparator group, n = 25 20.3 11.6 14.6 11.2 −5.7 16.7
Urinary incontinence, ICIQ-UI, 0-21 (median, IQR)
Intervention group, n = 23 4.0 8.0 3.0 6.0 0.0 3.0 .370a 
Comparator group, n = 25 3.0 4.5 3.0 6.5 0.4 1.5
(Continues)
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previous RCT by Haugstad et al25 The clinical relevance of a differ-
ence of only 1.2 must be questioned, despite its statistical signifi-
cance. Approximately one quarter of the women in the intervention 
group reported unchanged or worse mean pain intensity scores, 
which contrasts with results by Haugstad et al, where only one of 
the 19 women in the group receiving physical therapy combined 
with cognitive techniques reported unchanged pain intensity.25 This 
possibly reflects the differences between the study samples, but it 
could also indicate a need for refining both the study intervention 
and selection criteria. Some women with CPP may respond better to 
individual treatment. Group-based treatment as well as treatments 
aiming to change personal habits can be challenging for some pa-
tients.7 Future studies should investigate predictors for different 
treatment approaches.29
A recently published RCT on 49 women with CPP by Ariza-
Mateos et al compared a combination of manual physical therapy, 
exercises, and pain education with manual physical therapy alone.30 
The primary outcome was fear-avoidance behavior, which showed 
significantly more improvement in the combined treatment group. 
The difference between the groups regarding pain reduction was 
1.1, which was similar to our result. The larger difference between 
the groups in the study by Haugstad et al could be because the com-
bined physical therapy treatment was compared with standard gy-
necological care only, and the participants had higher baseline pain 
scores.25
The greatest reduction in mean pain intensity in the interven-
tion group was observed between 6 and 12 months. This sug-
gests that the long duration of the treatment is important, which 
is in accordance with theories of behavioral change that emphasize 
that it takes time to integrate new experiences and obtain lasting 
changes.31 A subject for future studies would be to perform another 
follow up 12 months after the end of treatment.
Reduced pain intensity reflects only one aspect of posi-
tive changes for women with the complex condition of CPP, and 
selection of appropriate end points is challenging.1,2 The greater 
improvements in respiratory patterns and pain-related fear of 
movement in the intervention group corroborate with the previ-
ous results presented by Haugstad et al25 and Ariza-Mateos et al.30 
Improved respiratory patterns, in terms of increased deep respi-
ration with abdominal expansion, may be related to the relaxation 
techniques and body awareness therapy applied in the study inter-
vention, so may be related to pain reduction. Pain-related fear of 
movements is emphasized as a key mechanism for the development 
and maintenance of chronic pain, and hence it is a relevant outcome 
to include.32
For health-related quality of life, we observed that the base-
line scores for EQ5D-5L were low compared with the population 
scores.33 No significant differences in change were found for ei-
ther the EQ5D-index or EQ-VAS scores. In future studies, a symp-
tom-specific measure of health-related quality of life might add 
more information, because EQ5D-5L may not be sufficiently re-
sponsive to detect changes.34 Differences between the groups for 
symptoms of anxiety and depression were not observed. The out-
come measures for sexual, urological, and bowel functions were 
included according to the CPP definition,2 and no group differ-
ences were detected.
Studying complex interventions for a complex condition such as 
CPP has several challenges. The optimal treatment is still uncertain, 
and more research is needed to refine the multimodal interven-
tion, probably by tailoring the treatment for different subgroups of 
women with CPP.
5  | CONCLUSION
The reduction in the mean pelvic pain with group-based multimodal 
physical therapy was significantly more than that of primary-care 


















IQR Mean 95% CI P
Anal incontinence, St. Marks 0-24 (median, IQR)
Intervention group, n = 24 0.0 2.0 0.0 2.0 0.0 0.0 .120a 
Comparator group, n = 25 0.0 7.5 0.0 4.0 0.0 2.0
Obstructed defecation, ODS 0-25 (median, IQR)
Intervention group, n = 25 5.0 8.0 6.0 7.0 −2.0 4.0 .337a 
Comparator group, n = 25 7.0 8.0 6.0 7.0 0.0 3.5
Note: Bold values are statistically significant (P < .05).
Abbreviations: HSCL-25, Hopkins Symptom Check List; ICIQ-UI; ICIQ -Urinary Incontinence Short Form; IQR, interquartile range; NRS, numeric 
rating scale; ODS, obstructed defecation score; SD, standard deviation; SHC, Subjective Health Complaints questionnaire; SMT, Standardized 
Mensendieck Test; TSK-13, Tampa Scale of Kinesiophobia.
aMann-Whitney U test. 
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was not found, and we cannot conclude that a group-based inter-
vention including body awareness therapy, patient education, and 
cognitive techniques is clinically better than primary-care physical 
therapy for women with CPP.
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Appendix 1 Schedule for the first 10 days of the group-based multimodal physical therapy intervention 
Week 1 Monday Tuesday Wednesday Thursday  Friday 
08.30 Individual assessments, 
including the SMT-test 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
09.00 
10.00 Patient education and 
workbook:  
To live with chronic pain 
Reflection about own pain 
situation 
Patient education: Pelvic 
anatomy, physiology and 
functions 
Patient education: Coping 
strategies  
Patient education: 
Physical activity and 
pain 
Information and presentation 
11.30 Movement break Movement break Movement break Movement break 
11.45 
12.30 Movement and body 
awareness therapy: Intro 
Patient education: Pain 
neurobiology  
Patient education: and 
workbook: Introduction to 
ACT Change of focus 
Movement and body 
awareness therapy 
Patient education and 
workbook: ACT 
To set goals 
14.00 Individual assessments, 
including the SMT-test 
Movements and 
relaxation 
Movement and body 
awareness therapy 
Movements and relaxation Movements and 
relaxation 
Week 2 Monday Tuesday Wednesday Thursday  Friday 
08.30 Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
Movement and body 
awareness therapy (pool) 
09.00 
10.00 Patient education: Relaxation 
and breathing in relation to 
pain 
Patient education: Muscle 
function 
Workbook:  Reflection about 
own future 
Patient education and 
workbook:  
ACT 
To set goals 
Patient education and 
workbook: 
Making long-term goals 
11.30 Movement break Movement break Movement break Movement break Movement break 
11.45 
12.30 Patient education: The 
autonomous nervous system 
Patient education: Pelvic 
pain (gynecologist) 
Patient education: Nutrition 
(nutritionist) 
Movement and body 
awareness therapy 
Evaluation 




Movement and body 
awareness therapy 
ACT, acceptance and commitment therapy 
Appendix 1
TIDieR	checklist	
Appendix 2: The TIDieR (Template for Intervention Description and Replication) Checklist 
Item 
number 
Group-based Multimodal Physical Therapy for women with Chronic Pelvic Pain 
Description of the intervention 
Where located 
Page number in 




1. Group-based multimodal physical therapy
WHY
2. The primary aim of the intervention is to challenge habits of avoidance, give new positive bodily experiences and to
facilitate change in terms of reduced pain and improved daily function.1-3
The theoretical basis is that the body is seen as a functional and interacting entity with indivisible body and mind, and that
physical and psychological strains over time may influence the whole body.4 5
The treatment program is in accordance with the latest clinical guidelines for CPP, which recommend a holistic approach
enhancing both physical, psychological, social and sexual factors, active patient involvement and provision of information
that is responsive to the patient’s problems.6
Page 7 
HOW
3. The treatment program consists of a total of 16 days organized as one 10-days session followed by two-day sessions after 3,
6 and 12-months. A one-day program starts at 8.30 and lasts until 15.00, with a combination of movement classes, lectures
and discussions every day. There is a pre-planned schedule for all the 16 days.
The intervention is a combination of movement therapy2, 5 patient education1, 7 and Acceptance and Commitment Therapy
(ACT).8 A more detailed description is given under “Procedures”.
The study intervention is run by physical therapists with competence in psychosomatic physical therapy and chronic pain
management. A gynecologist and a nutritionist contribute on one lecture each.
The treatment program starts and ends with an individual physical therapy assessment, and the rest of the program is given in







Referral and inclusion: The participants are recruited from the multidisciplinary Pelvic Floor Center at the University
Hospital of North Norway (UNN), after assessment by a medical specialist. Written and oral study information is given, and
consent forms signed in accordance with the principles of the Declaration of Helsinki.
First assessment: An individual physical therapy assessment is performed on day one or two. The anamnesis covers
predetermined questions about patients´ perception of cause of CPP, challenges in the daily life, thoughts about need for
more medical examinations, previous assessments and treatment, childhood, expectations to the program, hobbies, interests
and social life. A physiotherapeutic assessment is performed, including an introduction to body awareness exercises. The
first assessment has a time limit of 60 minutes.
Daily program: Every day of the program has the same basic structure; hydrotherapy in a heated pool (32°C) (60 minutes),
two sessions of lectures (90 minutes each), short “movement break” (15 minutes), body awareness therapy in the gym (60
minutes). The detailed description of the intervention components are:
1. Body awareness therapy:
Explorative exercises aiming to increase the awareness of own respiration- and movement patterns, of posture and of the
difference between muscle tension and relaxation were applied.5 Reflections about how these functions are influenced by
each other and by physical, emotional or social strain were integrated in the movement classes.2, 5 The participants are
challenged to gradually re-introduce movements or functions that have been restricted or avoided.
The body awareness therapy is performed with different types of exercises, both in the gym and as hydrotherapy. 
Exercises in the gym include: 
- Awareness exercises focusing on own respiration, movement patterns, posture and the difference between muscle
tension and relaxation.5
- Pelvic floor muscle exercises, especially focusing on recognition of tension versus relaxation.
- Establishing solid postural stability, i.e. to be able to stand firmly on one’s legs or to be properly “grounded”9
- Exploration and re-introduction of functional movements that has been avoided or restricted.
- Reflections about how the different functions can be related and/or influenced by each other, such as muscle tension
linked to respiration, posture is linked to respiration and muscle tension etc.
- Progressive relaxation, one session every day.





stability and strength. The reduced weight bearing, the warm water and the compressive effects of hydrostatic pressure are 
considered to have favorable effects for adults with musculoskeletal pain.10 
2. Patient education:
Patient education with lectures about topics related to living with CPP, both focusing on the biological and psychosocial
factors connected to pain. Special attention is given to the role of the autonomic nervous system in pain, and why pain can
persist despite lack of objective findings and after the expected time for tissue healing.1, 7
The following topics are addressed in the lectures: 
- Pain neurobiology
- “The body”: pelvic anatomy, urinary and bowel functions, sexual function, diaphragm-model (respiration) and the
autonomous nervous system.
- Nutrition (by a nutritionist)
- Pelvic pain (by a gynecologist)
- Living with chronic pain
- Muscle function
- Change of focus
- To set goals (three sessions)
- The associations between unrestricted respiration, ability to rest and sense of security.
- Coping strategies
- Acceptance and Commitment Therapy (ACT)
- The relation between movements/ physical activity and pain
Group discussions and individual tasks related to the topics are a part of the educational sessions. 
3. Acceptance and Commitment Therapy (ACT):
ACT focuses on behaviour change rather than symptom reduction, and the aim is to help the women to accept that the pain is
present, set goals and commit to use available resources despite the pain.3, 11, 12 ACT includes mindfulness (learning to see
your thoughts in a new way, not let the pain define you), acceptance (accepting that the pain is present, but not letting it
define your life), commitment and values based living (do things you want, try to get in touch with your desired life).3 ACT
is incorporated both in the education and movement therapy.
5. MATERIALS:
TIDieR	checklist	
Equipment: For exercises in the gym soft therapy mats, exercise balls (size 60-75 cm) and wooden rollers are used. Pillows 
and blankets are available in the gym/therapy room. For the hydrotherapy flotation devices (“pool noodles”) are used.  
A compact digital camera and a tripod are used to record participants performing SMT-test before and after treatment. 
Furniture needed is a big table and chairs to seat all participants and physical therapists. 
Workbook: The participants receive a workbook with short texts covering the topics presented in the lectures. The 
workbook also contains individual tasks for the women to work with between the sessions (a copy in Norwegian can be 
obtained by contacting the first author, ASN). 
Manual for the Standardized Mensendieck Test: The Standardized Mensendieck Test is video taped both at the start and 
at the end of the treatment period, and is used as an educational tool to illustrate to participants the changes they achieve 
during the treatment period. The test is a physiotherapeutic test developed to assess movement quality in women with CPP. 
Posture, movement, gait, sitting posture and respiration are evaluated.13 A copy in Norwegian can be obtained by contacting 
the first author, ASN.	
Website developed by the Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health with information in 
Norwegian language about chronic pelvic pain and with sound files with instructions for pelvic floor muscles exercises, 
progressive relaxation, and mindfulness and for relaxation before going to bed (to promote sleep). The website is public. 








WHO PROVIDED  
6. The study intervention is run by three physical therapists with competence in psychosomatic physical therapy and chronic
pain management. A gynecologist and a nutritionist contribute on one lecture each.
WHERE
7. The location for the treatment program is outside the hospital. A combined gym and a teaching room, a heated pool (32°C)
and a therapy room used for the individual talks and the assessment are the premises used, in addition to a restroom. The
gym was comfortably heated and the level of light could be adjusted during the different movement tasks. The participants
themselves book accommodation, and payment is largely refunded from the Norwegian Health Authorities
(Pasientreiser/HELFO).
WHEN and HOW MUCH 
8. The first session lasts for 10 coherent days, and then there are two-day sessions after three, six and 12 months. After each
session the participants go back to their homes and to their normal daily life.
TIDieR	checklist	
TAILORING 
9. The program is designed for the group setting, and the participants are encouraged to participate in the entire program. Still,
some participants express strong wishes about not participating in e.g. pool exercises, and then receive alternative exercises.
MODIFICATIONS
10.ǂ A total of six treatment groups were run before a sufficient number of participants for the trial had completed. No specific
modifications were done, but variations will always be present between different groups although the basic program is the
same.
HOW WELL
11. The physical therapists have a pre-planned schedule with descriptions of topics for theoretical lectures, and an “exercise
bank” for the practical lessons.
The participants’ adherence to the intervention was recorded at 12 months by registration of number of days attended..
12.ǂ Of the 32 women starting the treatment program in our study, 26 completed.


















Til fysioterapeut som får henvist pasient:  
Informasjon om forskningsprosjekt på kroniske bekkensmerter
Ved UNN Tromsø pågår nå et forskningsprosjekt på kroniske bekkensmerter hos kvinner. Prosjektet 
innebærer at en del kvinner henvises for oppfølging hos fysioterapeut nær pasientens hjemsted, 
slik vanlig praksis for behandling av denne pasientgruppen er. Denne informasjonen sendes til 
fysioterapeuter som får henvist pasienter som deltar i prosjektet. 
Hensikten med prosjektet er å sammenligne effekten av en gruppebasert behandling i regi av UNN 
Tromsø, med det å få oppfølging hos fysioterapeut lokalt. Det gjennomføres en randomisert 
kontrollert studie, hvor deltakerne trekkes til å motta ett av de to behandlingsalternativene.  
Deltakerne i prosjektet er kvinner med langvarige smerter i bekken eller underliv. De er utredet hos 
gynekolog, gastrokirurg eller urolog, og malignitet eller andre tilstander som krever medisinsk eller 
kirurgisk behandling skal være avkreftet før inklusjon i prosjektet. Deltakerne følges opp i ett år, 
med registrering av opplysninger om smerte, livskvalitet og andre helseplager. Dersom de ønsker vil 
deltakerne etter studieperioden få tilbud om deltakelse i gruppebehandlingen i Tromsø. 
Vi er klar over at det er variasjon i innhold og organisering av fysioterapibehandling hos ulike 
terapeuter i primær- og spesialisthelsetjenesten, og behandlingsopplegg for den enkelte avgjøres 
av fysioterapeut i samråd med pasient. Vi ønsker at du skal behandle denne pasienten slik som du 
ville gjort uavhengig av at hun deltar i et forskningsprosjekt.  
Vi er takknemlige for om ventetiden før oppstart av behandling blir så kort som mulig. Dersom 
pasienten ønsker å bytte til annen behandler underveis i perioden er dette i orden, men vi er da 
takknemlige for om henvisning sendes med videre eller at det bes om ny henvisning. Deltakere i 
prosjektet får refundert utgifter (egenandel) ved behandling hos fysioterapeuter med refusjonsrett. 
De må derfor ta vare på kvitteringer. Eget refusjonsskjema sendes til pasient. 
Ved spørsmål er du velkommen til å ta kontakt med oss. 
Vennlig hilsen 
Ane Sigrid Henriksen 
Fysioterapeut MSc/ PhD-stipendiat, Nasjonal kompetansetjeneste for inkontinens og 
bekkenbunnsykdom. 
Kontakt:  
Torunn Pedersen, prosjektkoordinator 
Tlf.: 77627267 (ti, to fre oddetallsuker). Torunn.K.pedersen@unn.no 
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Conservative treatment of chronic pelvic pain
Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom
E-mail: ane.sigrid.henriksen@unn.no
Phone: +47 92 2* ** **
Background information at inclusion
1 / 5
Participant initials:
Participant number:Date: . .
Previous treatment by physical therapist at KIB: Yes No
Exclusion criteria:
Yes No
Major intra-abdominal, vaginal or rectal surgery during the last 6 months: Yes No
Pregnancy and childbirth last 12 months: Yes No
Not Norwegian speaking: Yes No
Drug addiction, or use of larger doses of analgesics: Yes No
Severe psychiatry, or not consent competence: Yes No
Yes No
Pain only during menstruation that is not associated with negative consequences
of cognitive, behavioral, sexual or emotional nature:
Botox injection during the last 4 months: Yes No
Detected malignant disease of the pelvis or other medical treatment requiring
pathology of the pelvis (including initiation of systemic hormone therapy):
If yes: May be included later if possible to achieve 6 months after surgery first.
Surgical intervention date: . .
Can be included from date: . .
If yes: Can be included later if possible to achieve 4 months without Botox first.
Last injection date: . .
Can be included from date: . .
Inclusion criteria:
Female 20-65 years: Yes No
Pelvic / abdominal pain> 6 months: Yes No
Motivated to participate in group-based treatment in Tromsø: Yes No
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Conservative treatment of chronic pelvic pain
Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom
E-mail: ane.sigrid.henriksen@unn.no
Phone: +47 92 2* ** **
Background information at inclusion
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Student / military service
Sick leave






Vaginal delivery (number): Spontaneous (number): Operational (vacuum / forceps):
Caesarean section (number):
Number of abortions:
 (Tick one ore more boxes)
Demographic variables:
Age (year):
Height (cm): Weight (kg): ,
Highest completed education: Primary school
Vocational higher education, vocational school
Upper secondary school
College or university, less than 4 years
College or university, 4 years or more
Year of birth:
Civil status: Married/cohabiting Live alone/ single
Do you smoke: Yes No
BMI: ,
If yes, enter percentage:
 (Tickt only one box)
Year of childbirths: 1. 2. 3. 4.
5. 6. 7. 8.
9. 10.
Extra-uterine pregnancy: Yes No If yes, number:
Surgical intervention: Yes No
Specify:
Have you been on sick leave due to the pelvic pain during the last 3 years? Yes No
If yes: - total weeks last 3 years: - total number of weeks last year:
Episiotomy (number):
Participant number:
Conservative treatment of chronic pelvic pain
Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom
E-mail: ane.sigrid.henriksen@unn.no
Phone: +47 92 2* ** **
Background information at inclusion
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Do you consider yourself to be sufficiently assessed/examined? Yes No
Previous surgery in the abdomen or pelvis: Yes No
how long since the last: Total number of surgeries:If yes:
Background / cause of the pain:
Can you describe the type of pain:
Localization:
How often pain:
Triggering factors / when does the pain occur:
What is your main bother: Pain in the pelvic area General pain in the body
When started the pain condition in abdomen / pelvis: 6 months ago
7 - 12 months ago
1 - 2 years ago
2 - 4 years ago
4 - 6 years ago
6 - 10 years ago
More than 10 years ago
How long has the pain in the abdomen / pelvis been at the same level as now?
0 - 3 months 4 - 6 months 7 - 12 months 1 - 5 years 6 years or more
Treatment and pain related variables:






Conservative treatment of chronic pelvic pain
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Neurological disease / injury
Repeated UTI during the last 1-2 years
Endometriosis
Ovarian cysts (right / left). Treated?
Other
Type:
If sphincter damage, degree:
Systemic disease: Yes No
If yes, specify:
Neurological disease, injury or surgery: (If necessary, add several crosses)
Back injury (incl. Prolapse) MS Cerebral insult Other
Previous treatment of pelvic / abdominal pain (other than surgery, eg radiation, physiotherapy, etc.):
Yes No
Do you use medication in relation to pelvic pain: Yes No
How much do you usually take daily? (Number of tabl, suppositories)
Painkillers, over the counter: A B C D A: Less often than every week
B: Every week, but not daily
C: Daily
D: Not used
If yes, specify the type and frequency of use for the last 4 weeks:
Painkillers on prescription: A B C D
Sleeping aids: A B C D
Beroligende medicines: A B C D
Anti-depressants: A B C D
A B C D
If other, specify:
Other:




Conservative treatment of chronic pelvic pain
Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom
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Absence of menstruation due to hormone spiral or similar
Interval and duration (eg 30/5):
Interval and duration:
Pre- or postmenopausal: Premenopausal
Postmenopausal Date of last menstrual period:
Any menopause disorders: Yes No
Do you have any complaints other than those associated with the pelvic area:
Are there anything else than what we have talked about until now you put in context with your pelvic
complaints, el. other things you want to add:
Have you been exposed to incidents that you experienced as abuse, of a physical, mental or sexual nature:
Yes No
If yes: (Put only one cross) Got help Have not received help
Approximate time (child / adult):
 (Sett kun ett kryss)
Menstruation
If pre-, you have dysmenorrhea / much pain associated with menstruation: Yes No
Any other information:






Smerte (i underlivet) ved samleie:





Er du seksualt aktiv?:
Ja Nei
Annet (spesifiser):
Spørsmål om mulige problemer knyttet til seksualitet og til samleie
Har noen av alternativene som er nevnt nedenfor forekommet i ditt seksualliv i løpet av de siste
12 mnd?
Manglende/liten seksuell lyst:
Hele tiden Nesten hele tiden Ganske ofte Ganske sjelden Aldri
Sett et kryss pr linje:
0 1 2 3 4 5 6 7 8 9 10
Hvis smerter ved samleie, angi grad av smerte på skalaen under. Verdi ”0” indikerer ”ingen smerter”






Konservativ behandling av kroniske bekkensmerter
Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom
E-post: ane.sigrid.henriksen@unn.no
Tlf.: +47 92 25 85 82
Seksualfunksjon
Hvis nei, angi grunn:
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2014/1398  Kroniske bekkensmerter hos kvinner - konservativ tverrfaglig behandling i gruppe
sammenlignet med standard behandling. 
 Institutt for Klinisk Medisin (IKM)Forskningsansvarlig institusjon:
 Pål ØianProsjektleder:
Vi viser til søknad om forhåndsgodkjenning av ovennevnte forskningsprosjekt. Søknaden ble behandlet på
fullmakt av Regional komité for medisinsk og helsefaglig forskningsetikk (REK nord).  
Prosjektleders prosjektomtale
Kroniske bekkensmerter (KBS) er en tilstand som medfører store plager. Det finnes begrenset kunnskap om
årsak og behandling av KBS. Nyere retningslinjer anbefaler helhetlig og tverrfaglig tilnærming, og det
etterspørres studier på dette. Ved UNN er det startet et tverrfaglig gruppetilbud for kvinner med KBS.
Formålet med dette prosjektet er å undersøke effekt av gruppetilbudet sammenlignet med effekt av standard
individuell behandling. Resultatene vil gi økt kunnskap om pasientgruppen og om effekt av
behandlingstilnærmingene, som igjen kan bidra til forbedret behandlingstilbud. Pasienter med KBS som
skal behandles konservativt kan delta i studien, og de trekkes tilfeldig til å motta ett av
behandlingstilbudene. Behandlingen går over ett år. Opplysninger om smerte, livskvalitet og andre
helseplager samles inn med spørreskjema, og fysioterapeutisk undersøkelse gir opplysninger om
bevegelseskvalitet og respirasjon. Målinger gjøres ved start, og etter 6 og 12 måneder. Mer info i protokoll.
Vurdering
Vi viser til skjema for tilbakemelding av 09.11.14.
Rek anser at tilbakemeldingen er i tråd med der merknader komiteen gav i sitt utsettelsesvedtak av 29.9.14
Etter fullmakt er det fatte slikt:
Vedtak
Med hjemmel i helseforskningsloven §§ 2,9 og 10, samt forskningsetikkloven § 4 godkjennes prosjektet.
Sluttmelding og søknad om prosjektendring
Prosjektleder skal sende sluttmelding til REK nord på eget skjema senest 01.09.2018, jf. hfl. §
12. Prosjektleder skal sende søknad om prosjektendring til REK nord dersom det skal gjøres vesentlige
endringer i forhold til de opplysninger som er gitt i søknaden, jf. hfl. § 11.
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Klageadgang
Du kan klage på komiteens vedtak, jf. forvaltningsloven § 28 flg. Klagen sendes til REK nord. Klagefristen
er tre uker fra du mottar dette brevet. Dersom vedtaket opprettholdes av REK nord, sendes klagen videre til







Forespørsel om deltakelse i forskningsprosjektet 
”Konservativ behandling av kroniske bekkensmerter” 
Bakgrunn og hensikt 
Kroniske smerter i bekken/underliv medfører store plager og redusert livskvalitet for mange kvinner. 
Slike smerter kan ha sammensatte årsaker og man har dessverre begrenset kunnskap om hva som er den 
beste behandlingen. 
Dette er en forespørsel til deg om å delta i et forskningsprosjekt for å undersøke effekt av to ulike 
behandlingsalternativer. Ved Universitetssykehuset Nord-Norge (UNN) i Tromsø er det startet et 
gruppebasert behandlingstilbud til kvinner med kroniske bekkensmerter. Vi er usikre på effekten av 
gruppetilbudet sammenlignet med det som er vanlig behandlingstilbud på landsbasis, nemlig individuell 
oppfølging hos fysioterapeut med egnet kompetanse nærme pasientens hjemsted. I dette 
forskningsprosjektet ønsker vi å undersøke effekten av disse to behandlingstilbudene nærmere. 
Hva innebærer studien? 
Hvis du takker ja til deltakelse vil du innkalles til fysioterapeut ved UNN.  Det registreres informasjon 
om deg og dine plager, og det gjennomføres en fysioterapitest. Etter testen trekkes du tilfeldig til et av 
behandlingsalternativene. Vi følger deg opp i ett år for å vurdere effekt av behandlingstilbudet du får. 
Mulige fordeler og ulemper 
Dersom du deltar vil du være med å tilføre fagfeltet ny viktig kunnskap, og du vil få mulighet til å gi 
tilbakemelding om hvordan du opplever det tilbudet du har fått. Deltakelse i studien innebærer at du i 
tillegg til behandlingen du får skal møte fysioterapeut ved UNN to ganger i løpet av et år. Dette kan for 
noen oppleves som en ulempe pga tidsbruk, mens andre kan oppleve at dette er en fordel fordi man får 
flere samtaler med fysioterapeut. Studien varer i ett år etter oppstart av behandling, og det er av stor 
betydning for resultatene at du deltar helt til testing etter et år er gjennomført. 
Hva skjer med informasjonen om deg? 
Informasjonen som registreres om deg skal kun brukes slik som beskrevet i hensikten med studien. Alle 
opplysningene vil bli behandlet uten navn, fødselsnummer eller andre direkte gjenkjennende 
opplysninger. En kode knytter deg til dine opplysninger gjennom en navneliste. Det vil ikke være mulig 
å identifisere deg i resultatene av studien når disse publiseres.  
Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke ditt samtykke 
til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling. Dersom du ønsker å delta, 
undertegner du en samtykkeerklæring før inklusjon i studien. Dersom du har spørsmål kan du kontakte: 
UNN HF, Nasjonal kompetansetjeneste for inkontinens og bekkenbunnsykdom: Torunn Pedersen, 
prosjektkoordinator. Tlf.: 77627267 (ti, to, fre i oddetallsuker). E-post: torunn.k.pedersen@unn.no. 
Prosjektgruppen består av: 
Ane Sigrid Henriksen  
Fysioterapeut MSc/Stipendiat 
Nasjonal kompetansetjeneste 
for inkontinens og 
bekkenbunnsykdom, UNN 
HF, Tromsø  
ane.sigrid.henriksen@unn.no 
Pål Øian  
Professor/Overlege 
Kvinneklinikken,  
UNN HF, Tromsø  
pal.oian@unn.no 
Mona Stedenfeldt  
Fysioterapeut PhD/ Faglig rådgiver, 
Nasjonal kompetansetjeneste for 
inkontinens og bekkenbunnsykdom, 
UNN HF, Tromsø, 
mona.stedenfeldt@stolav.no 




Høgskolen i Oslo og 
Akershus  
grokilli.haugstad@hioa.no 
Ytterligere informasjon om studien finnes i kapittel A. 
Ytterligere informasjon om personvern og forsikring finnes i kapittel B. 
Samtykkeerklæring følger etter kapittel B.
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Kapittel A- utdypende forklaring av hva studien innebærer 
Bakgrunn for studien 
Kroniske bekkensmerter er et sammensatt og belastende helseproblem for de som rammes, og det er et stort 
behov for mer kunnskap om hvordan man skal behandle slike plager. Vi ønsker å se nærmere på to 
behandlingstilbud som gis i dag, for å kunne gi et best mulig tilbud til kvinner med slike smerter. Studien 
inngår i doktorgradsprosjektet ” Konservativ behandling av kroniske bekkensmerter” som gjøres av 
fysioterapeut Ane Sigrid Henriksen i samarbeid med Nasjonal Kompetansetjeneste for inkontinens og 
bekkenbunnsykdom ved UNN. 
Undersøkelser ved inklusjon i studien 
Dersom du samtykker i deltakelse i studien vil du bli innkalt til et møte med fysioterapeut ved UNN. 
Gjennom en samtale registreres relevant informasjon om dine plager (varighet, tidligere behandling etc). 
Deretter gjennomføres en fysioterapitest med fokus på daglige bevegelsesoppgaver. Under denne testen skal 
du ha på deg klær som gjør det lett å observere hvordan du beveger deg (f.eks shorts og singlet). Testen 
videofilmes for at forsker senere skal kunne sammenligne filmen med en som tas etter endt behandling. I 
løpet av møtet med fysioterapeut fyller du ut spørreskjemaer som går på smerte, livskvalitet, funksjon i 
daglige aktiviteter og generelle helseplager. Totalt vil dette møtet ta ca 1,5 time. 
Tilfeldig trekking av behandlingsalternativ 
En datamaskin avgjør ved ”randomisering” (loddtrekning) hvilken behandling du skal få. Du får informasjon 
om hvilken behandling du er trukket til over telefon og per post. 
Gruppebehandling i Tromsø eller individuell fysioterapi nær ditt hjemsted 
Den gruppebaserte behandlingen består av 4 samlinger i Tromsø fordelt over 12 måneder, hvorav den første 
samlingen er på to uker og de påfølgende på to dager. Dersom du blir trukket til å få oppfølging lokalt får du 
henvisning til fysioterapeut med egnet kompetanse så nærme ditt bosted som mulig. Du vil da få tilbud om å 
delta i gruppebehandlingen etter et år, dersom du ønsker dette. 
Oppfølging underveis i studien 
Ved deltakelse vil du få tilsendt fire spørreskjemaer i posten etter 3 og 6 måneder. Du blir også ringt opp 
med påminnelse om å returnere skjemaene. Etter 12 måneder blir du igjen innkalt til en time hos 
fysioterapeut på UNN. De samme registreringene som ved første møte gjennomføres. 
Kriterier for deltakelse 
For å vite at det er effekten av fysioterapibehandlingen vi måler ønsker vi at du ikke skal motta annen 
inngripende behandling i bekken/underliv mens du deltar i prosjektet. Dette kan f.eks være kirurgi, 
injeksjoner, blæreinstillasjoner, eller oppstart av ny hormonbehandling. Dette er årsaken til at vi før 
inklusjon ber om at du er utredet hos lege og derfra henvist til konservativ oppfølging. 
Dersom annen behandling blir nødvendig i løpet av studieperioden skal du selvfølgelig ha det, men vi 
ønsker å få vite dette. Smertestillende medisiner og annen behandling som ikke er inngripende (som TENS, 
fysioterapi, osteopati, øvelser etc) er tillatt. Du er velkommen til å ta kontakt med oss dersom du har 
spørsmål i forhold til dette i løpet av månedene studien pågår.  
Testing ved avbrutt behandling 
Vi håper du vil benytte deg av behandlingstilbudet du blir trukket til, at du vil returnere spørreskjema etter 3 
og 6 måneder og møter opp til testing etter 12 måneder. Dette er av stor betydning for å oppnå best mulig 
kvalitet på resultatene av studien. Vi vil også spørre deg om å fylle ut spørreskjema og møte til 12-måneders 
testing om du ikke har kunnet følge opp behandlingen du ble trukket til.  
                                  
  
Frivillig deltakelse 
Dersom du velger å ikke delta i studien vil du få det tilbudet for konservativ oppfølging som gis ved UNN i 
dag. Dette er henvisning til oppfølging lokalt, individuell fysioterapi ved UNN eller gruppebehandling. 
Ventetid må da påregnes. 
 
Kapittel B - Personvern, økonomi og forsikring 
 
Personvern 
Opplysninger som registreres om deg er bakgrunnsinformasjon om dine plager, opplysningene du gir på 
spørreskjemaene og video av fysioterapiundersøkelsen. Alle data blir anonymisert, og merket med dine 
initialer og et deltakernummer. Det er kun prosjektkoordinator og fysioterapeuten som gjennomfører testing 
ved oppstart og avslutning av prosjektet som har adgang til navnelisten og som kan finne tilbake til deg. 
 
Videofilmen vil ikke vises til andre enn fysioterapeutene involvert i forskningsprosjektet, samt at du selv 
kan få se den om du ønsker. 
 
Fysioterapeut Ane Sigrid vil ha tilgang til din pasientjournal, men har kun tillatelse til å bruke den for å 
innhente opplysninger som er nødvendige i forhold til studien og vil da informere deg om at dette blir gjort. 
Informasjonen som er lagret og bildene som er tatt skal slettes 3 år etter at datainnsamlingen avsluttes. 
Universitetssykehuset Nord-Norge ved administrerende direktør er databehandlingsansvarlig. 
 
Rett til innsyn og sletting av opplysninger om deg  
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om deg. 
Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du trekker deg 
fra studien, kan du kreve å få slettet innsamlede opplysninger, med mindre opplysningene allerede er inngått 
i analyser eller brukt i vitenskapelige publikasjoner. 
 
Økonomi  
Omkostninger ved reise og opphold dekkes etter gjeldende regler fra Pasientreiser. Dette vil si at du som ved 
ordinær behandling, reise- eller opphold i forbindelse med behandling vil betale en egenandel. Du må sørge 
for å ta vare på kvitteringer på reiseutgifter slik at du får dekket det du har rett på.  
 
Egenandel ved oppfølging hos fysioterapeut med refusjonsrett (opp til egenandelstaket på 2670 kr per 
kalenderår) vil ved deltakelse dekkes av prosjektet. Det er viktig at du tar vare på kvitteringer slik at du får 
refundert disse utgiftene. Vi gjør oppmerksom på at dette kun gjelder for behandlere med refusjonsrett, og at 
vi ikke refunderer utgifter ved behandling hos fysioterapeut uten slik avtale med kommunen. 
 
Studien er finansiert gjennom forskningsmidler fra Fysiofondet og Helse Nord. 
 
Forsikring 
Pasientskadeloven gjelder ved deltakelse i studien på samme måte som ved vanlig oppfølging i 
spesialisthelsetjenesten. 
 
Informasjon om utfallet av studien 
Når resultatene fra studien publiseres vil de være tilgjengelige for deg. Det er planlagt publisering både i 
vitenskapelige tidsskrifter, og på nettsider og tidsskrifter for brukerorganisasjoner. 
 
       
                                  
  
Samtykke til deltakelse i studien 
”Kroniske bekkensmerter hos kvinner” 
 
 


































(BEHOLDES AV DELTAKER) 
  
Samtykke til deltakelse i studien 
”Kroniske bekkensmerter hos kvinner” 
Jeg har lest informasjonen og samtykker i å delta i studien 
---------------------------------------------------------------------------------------------------------------- 
(Prosjektdeltaker, dato) 
Jeg bekrefter å ha gitt informasjon om studien 
---------------------------------------------------------------------------------------------------------------- 
(Tester/fysioterapeut, dato) 
(RETURNERES TIL PROSJEKTLEDER VED SAMTYKKE TIL DELTAKELSE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
